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ABSTRACT
Many studies have demonstrated that following entorhinal cortex (EC) ablations, the
dentate gyrus (DG) of the hippocampus shows degeneration of the lesioned axons and
terminals, followed by a sprouting response of the surviving axons.  This lesion model has
frequently been used to elucidate the mechanisms underlying neuronal plasticity, it is also of
particular interest since it plays a critical role in learning and memory, and because of the
vulnerability of its circuitry to degeneration in Alzheimer’s disease and during the course of
normal aging.
The present studies characterize in detail the projections from the entorhinal cortex to
the hippocampal formation in mice.  The differences in these connections between mice and
rats are shown, and the differences between mice and rats following EC lesion-induced
sprouting are demonstrated.  Moreover, the presence of mutated genes and the effects of
estrogen depletion on the sprouting response in the mouse hippocampus are evaluated using
synaptophysin and acetylcholinesterase (AChE) staining.
The main findings of these studies are: I. The projections of the EC to the
hippocampus have a laminar and topographical distribution in the mouse.  The projection
from the EC to DG is unilateral, arising from layer II neurons, whereas the projections to
CA3, CA1, and subiculum are bilateral, and it originates predominantly from neurons in layer
III.  Neurons in the lateral part of both LEA and MEA project to the dorsal part of the
hippocampus, whereas the projection to the ventral hippocampus originates from neurons in
medial parts of EC.  II. Species differences are present in EC to hippocampal formation
projection, the main differences are: 1) the lack of a contralateral projection to DG in the
mouse, 2) layer III of the EC projecting to CA3 (compared to layer II in the rat) and 3) a more
limited septotemporal extent of the labeling in the hippocampus of the mouse.  III. The
process of neuronal reorganization after EC ablation in mice is similar to that in rats,
however, the process of neuronal degeneration is different.  Both species show an increase in
the density of staining for synaptophysin and AChE in the outer molecular layer of DG
following the EC lesion.  Further, it should be noted that, whereas rats demonstrate significant
shrinkage of the molecular layer of the DG following the denervation, mice do not show this
response.  IV. It has been suggested that Alzheimer’s disease-linked ps1 mutations deregulate
neurite growth.  We demonstrate that the presence of both the normal human ps1 gene or the
mutated human ps1* gene in mice, compared to the mouse ps1 gene, enhances plasticity
following EC lesions.  V. Our studies with estrogen depletion (ovariectomy) demonstrate that
in these mice axonal sprouting following lesions of EC is substantially reduced.  Estrogen
supplementation restores the sprouting response to the level of the non-ovariectomized,
normal mouse. 
Taken together, the present studies provide detailed information on the projections
from EC to hippocampus in mouse, further, we show the differences between mice and rats in
these projections.  We have demonstrated differences in the hippocampus in the response to
denervation between these two species, whereas we establish that the sprouting response is
similar.  We have analyzed the consequences of mutations (in the human ps1 gene) in mice, it
enhances plasticity following EC lesions, and finally, we show that hormone levels influence
the sprouting response, low levels of estrogen diminish sprouting.
National Library of Medicine Classification: WL 314
Medical Subject Headings: entorhinal cortex; hippocampus; dentate gyrus; neuronal plasticity;
sprouting; Alzheimer’s disease; estrogen; models; mice; rats; comparative study 
We and other animals notice what goes on
around us.  This helps us by suggesting what we
might expect and even how to prevent it, and
thus fosters survival.  However, the expedient
works only imperfectly.  There are surprises,
and they are unsettling.  How can we tell when
we are right?  We are faced with the problem of
error.
W. V. Quine, From Stimulus to Science
Reprinted by permission of the publisher from FROM STIMULUS TO SCIENCE by W. V. Quine, p.1,
Cambridge, Mass.: Harvard University Press, 
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INTRODUCTION
In recent years a consensus emerged about the role of the mammalian hippocampal
formation in learning and memory. However, the idea that the hippocampus is involved in
learning and memory functions is not in itself new.  Neuropsychological studies performed on
the famous amnesic patient H.M. (Scoville and Milner, 1957) have demonstrated clearly that
the medial temporal lobe (the hippocampus) is involved in memory.  Many studies in animals
and humans since that date have confirmed the hypothesis that the hippocampus is involved
in memory functions (e.g., Eichenbaum et al., 1992).  More recently it has been shown that
the entorhinal cortex (another area of the temporal lobe) is also involved in memory (e.g.,
Zola-Morgan and Squire, 1990).  
The entorhinal cortex (together with the perirhinal and parahippocampal cortices)
receives a wealth of information from many cortical association areas (Squire and Zola-
Morgan, 1991), and most of the projections from the association cortices to the entorhinal
cortex are reciprocal.  However, the main output of the entorhinal cortex is to the
hippocampus, and part of the output of CA1 and subiculum goes back to the entorhinal cortex
(Van Groen and Lopes da Silva, 1986; Van Groen et al., 1986; Witter et al., 1989a; Witter,
1993).  Taken together, it seems obvious that the entorhinal cortex is at a crucial, nodal point
in the circuitry connecting the hippocampus to the neocortex.  Therefore it should play an
important role in the functioning of the hippocampus, since it controls the flow of information
to (and from) the hippocampus. 
Alzheimer’s disease is clinically characterized by a progressive loss of memory and
other cognitive functions, resulting in dementia.  The intellectual decline is accompanied by
the accumulation of neurofibrillary aggregates in various cortical and subcortical regions of
the brain (Braak and Braak, 1991).  One of the primary changes seen in Alzheimer’s disease
(AD) is a loss of brain volume (first seen in the entorhinal cortex).  Main hallmark lesions of
the disease are the presence of large numbers of neurofibrillary tangles and neuritic plaques in
the cortex.  The temporal lobe, and especially the entorhinal cortex has been shown to be the
first cortical area that displays the neuronal pathology of AD (Braak and Braak, 1990, 1993). 
The pathology (i.e., the fibrillary aggregates) appears intracellularly as neurofibrillary tangles,
and extracellulary as amyloid plaques.  Most early onset AD is caused by mutations of the
amyloid precursor protein (app) gene and the presenilin1 (ps1) and presenilin2 (ps2) genes. 
Each of these affect APP metabolism and, therefore, amyloid$ protein production (e.g., Price
and Sisodia, 1998).  Further, relatively early in AD most neurons of the entorhinal cell layers
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II/III that give rise to the perforant path are lost (Hyman et al., 1990) leading to the loss of
synapses in the hippocampal formation (Cabalka et al., 1992) similar to an entorhinal cortex
lesion (ECL).  Thus, it has been suggested that ECL in rodents might induce morphological
changes in the hippocampus similar to those observed in AD patients.  Therefore the analysis
of the ECL model could lead to a better understanding of the processes underlying the
pathomorphological changes in AD (Cotman et al., 1990).
It has only recently been widely accepted that in mammals the CNS retains a lifelong
capacity for rearrangement of neuronal circuitry.  The physiological ability to modify synaptic
connections is maintained by the adult brain (e.g., Lynch and Cotman, 1975; Cotman and
Nadler, 1978; Cotman et al., 1981).  Numerous studies of lesion-induced forms of neuronal
plasticity have increased the hope that naturally occuring mechanisms exist which may lead to
a functional recovery of the human brain following trauma (for review see: Steward, 1994)
and an amelioration of functional deficits in the course of neurodegenerative disease (for
review see: Moore and Zigmond, 1994).
Studies performed in animals in the 1970's suggested that estradiol is a trophic
hormone in the brain during development.  More recent evidence suggests that it also exerts
these actions during adulthood (Gould et al., 1990; Woolley et al., 1990; Woolley and
McEwen, 1992).  Trophic effects have been reported in regions of the brain that express
estrogen receptor mRNA, protein, and binding, as well as in regions that appear to be receptor
poor. The findings that estradiol maintains the integrity and plasticity of neurons suggests that
estradiol-responsive neurons may have more resistance to injury and/or facilitated
regeneration from injury.  Increasing evidence demonstrates that estradiol influences
cognition and the incidence and progression of Alzheimer’s disease (Fillit, 1994; Sherwin,
1997; Henderson et al., 2000). 
17
2. REVIEW OF THE LITERATURE
2.1. Entorhinal cortex
The entorhinal cortex (EC) forms part of a larger set of structures that surround the
brain stem (Figure 1).  This belt of cortex has been called “le grand lobe limbique” (Broca,
1878) or “limbic system” (MacLean, 1952).  For a long time it was thought that the entorhinal
cortex was primarily related to olfactory functions, i.e., it was considered part of the
“rhinencephalon”, however more recently it has been shown to also be involved in functions
such as emotional and cognitive processes (Squire, 1992).  It has to be noted that the
entorhinal cortex does receive major inputs from the olfactory bulb and cortex.  Lately it has
become clear from many studies in many species (e.g., O’Keefe and Nadel 1978; Squire,
1992; Jarrard, 1993) that the entorhinal cortex, together with the hippocampus, contributes
importantly to learning and memory.  Especially in the rat and monkey, the role of the
entorhinal cortex in learning and memory functions has been extensively studied (e.g., Zola-
Morgan and Squire, 1990; Hagan et al, 1992; Jaffard and Meunier, 1993; Holscher and
Schmidt, 1994; Pouzet et al., 1999).  
The entorhinal cortex functions as the gateway to the hippocampal formation, because
its output, through the perforant pathway, it is the major cortical source of input to the
hippocampus (Figure 2).  Furthermore, together with the subiculum it also provides the major
output of the hippocampus (e.g., Witter et al., 1989a).  Ramón y Cajal was the first to clearly
describe fibers arising from the entorhinal area going to the fascia dentata and hippocampus
proper (i.e., cornu Ammonis; Ramón y Cajal, 1901).  This description has been confirmed and
extended by the studies of Lorente de Nó (1934).  Using the newly developed Golgi stain, he
gave a very detailed description of the types of neurons that are present in the entorhinal
cortex (Figure 1B).  The cells that give input to the hippocampus are predominantly present in
layers II and III, most neurons in layer II are modified pyramidal cells, or stellate cells,
whereas layer III predominantly consists of small pyramidal neurons (Figure 1B).  The deeper
layers of the entorhinal cortex (i.e., layers V and VI) contain slightly larger pyramidal
neurons, but the neurons of layer VI are smaller than those of layer V.  The neurons in these
layers, in general, do not project to the hippocampal formation, but to the cortex and
thalamus, respectively.  After this early work that has been mainly based on Golgi and fiber 
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Figure1
A, schematic drawing of the mouse cortex, indicating the position of the entorhinal cortex and
the hippocampus.  HIP-hippocampus, LEC-lateral entorhinal cortex, MEC-medial entorhinal
cortex, OB-olfactory bulb.  Space bar equals 1000 :m.
B, schematic drawing of a section through the Golgi-stained entorhinal cortex of the mouse
(modified after Lorente de Nó, 1934).
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stains, it has not been until the development of the “new” silver degeneration technique(s)
that new data have become available about these connections (e.g., Allen, 1948; Blackstad,
1958; Cragg, 1961; Raisman et al., 1965; Laatsch and Cowan, 1966; Nafstad, 1967; Hjorth-
Simonsen and Jeune, 1972).  Meanwhile, electrophysiological studies had demonstrated that
the axons of the perforant path constituted a powerful excitatory pathway to the hippocampus
proper (e.g., Green and Adey, 1956; Andersen et al., 1966).  More recently, modern tracing
studies performed in many species have confirmed that the entorhinal cortex projects by way
of the perforant path to the dentate gyrus and hippocampus (e.g., Van Hoesen and Pandya,
1975; Steward and Scoville, 1976; Wyss, 1981; Witter and Groenewegen, 1984; Witter and
Amaral, 1991; Dolorfo and Amaral, 1998b; Witter et al., 1989b).  It has been demonstrated by
a large number of studies in many species that the superficial layers of the entorhinal cortex
project to the hippocampus (e.g., Ramón y Cajal, 1901; Van Hoesen and Pandya, 1975;
Steward and Scoville, 1976; Ruth et al., 1982; 1988; Pohle and Ott, 1984; Witter and
Groenewegen, 1984; Witter et al., 1989; Dolorfo and Amaral, 1998b).  In the rat, the layer II
cells of the EC have been shown to project primarily to the dentate gyrus (e.g., Steward and
Scoville, 1976; Ruth et al., 1982; 1988; Tamamaki and Noyyo, 1993; Tamamaki, 1997;
Dolorfo and Amaral, 1998b).  The entorhinal cortex layer III cells have been shown to project
predominantly to CA1 and subiculum, and this projection is bilateral (e.g., Steward and
Scoville, 1976).  Some of the early studies (Hjorth-Simonsen and Jeune, 1972; Steward and
Scoville, 1976) showed evidence that a topographical organization likely existed in the
entorhinal-hippocampal projection.  Later studies have shown a topographical organization
such that the projection originating in lateral parts of the entorhinal cortex predominantly
terminated in septal (dorsal) levels of the dentate gyrus, whereas the axons arising from
medial parts of the entorhinal cortex preferentially terminate in the temporal (ventral) part of
the dentate gyrus (Ruth et al., 1982; 1988, Pohle and Ott, 1984; Witter and Groenewegen,
1984; Witter et al., 1989; Dolorfo and Amaral, 1998b).  It is an important issue that the
septotemporal distribution of entorhinal projections to the hippocampal formation is
dependent on the lateral-to-medial location of the projecting cells in the entorhinal cortex and
not on the origin in either medial or lateral entorhinal area.  However, it should be noted that
axons from the lateral entorhinal cortex terminate in the outer one-third of the dentate gyrus
molecular layer, whereas the medial entorhinal cortex terminals are found in the middle 
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Figure 2
Schematic drawing of a horizontal section through the entorhinal cortex and adjacent
hippocampus, indicating some of the interconnecting pathways.  The perforant path (pp)
arises from neurons in layers II and III of the entorhinal cortex, and passes through the
subiculum (SUB).  The axons from layer II neurons predominantly terminate in the outer two-
thirds of the molecular layer of the dentate gyrus (DG), whereas the axons from layer III
neurons project to stratum lacunosum-moleculare of CA3 and CA1, and the outer molecular
layer of the subiculum.  Arrows indicate areal borders, modified after Lorente de Nó, 1934.  
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molecular layer (e.g., Steward and Scoville, 1976; Wyss, 1981).  Further, the entorhinal
cortex innervates the whole hippocampal formation i.e., the dentate gyrus, CA3, CA2, CA1
and subiculum (Figure 2; Ruth et al., 1982; Ruth et al., 1988; Witter et al., 1989; Dolorfo and
Amaral,1998a; Van Groen et al., 2002).  Species differences in these connections (Hjorth-
Simonsen, 1972 [rat]; Wyss, 1981 [rat]; Witter and Groenewegen, 1984 [cat]; Dolorfo and
Amaral, 1988 [rat]) have been demonstrated.
2.2. Anatomy and connections of the hippocampal formation
The term hippocampal formation is commonly used to refer to the hippocampus
proper and dentate gyrus, although it has to be acknowledged that the term is sometimes also
used to include the subicular complex and sometimes even the entorhinal cortex (Amaral and
Witter, 1995).  We will use the term hippocampus referring to the dentate gyrus together with
fields CA3, CA2 and CA1, whereas hippocampal formation includes hippocampus and
subiculum (Figure 3).  Ramón y Cajal (1893) divided the hippocampus into two components:
dentate gyrus and Ammons horn, and Ammons horn was subdivided in an “upper” (also
labled regio superior) and a “lower” region (regio inferior).  This terminology has largely
been displaced by the terminology that was introduced by Lorente de Nó, i.e., dentate gyrus
and three subfields (CA1 [regio superior], and CA2 and CA3 [regio inferior]).  But, especially
in human and monkey literature the terms regio superior and regio inferior, and CA4 for hilus,
are still used. 
2.2.1. Dentate gyrus
The dentate gyrus consists of three layers: the molecular layer, the granule cell layer,
and the polymorph zone (Figure 3).  The principal cells of the dentate gyrus are the granule
cells, whose dendritic tree is confined to stratum moleculare.  The hilus, or polymorph zone
of the dentate gyrus, is located below the granule cell layer and is bordered by CA3.  The
principal, and most abundant, cell types of the hilus are the mossy and basket cells.  But many
other interneurons are present in the dentate gyrus and hilus (and hippocampus proper, for
review see Freund and Buzsáki, 1996), and these have projections that, in general, are related
to the type of interneuron, e.g., basket cells primarily innervate the cell body layer.  The
granule cells of the dentate gyrus are considered to be the first stage of the trisynaptic loop.
The major extrinsic source of innervation to the dentate gyrus originates in the 
neurons of layer II of EC (e.g., Steward and Scoville, 1976; Figure 2).  The EC projection
accounts for about 90% of the synapses in the outer two-thirds of the molecular layer
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(Steward, 1976; Steward and Vinsant, 1983).  It should be noted, however, that these contacts
are made on both the granule cell dendrites and the parvalbumin-positive interneuron
dendrites (Nitsch and Frotscher, 1993).  The perforant path is topographically organized such
that lateral EC projects to the outer molecular layer, whereas medial EC projects to the middle
molecular layer (Hjorth-Simonsen and Jeune, 1972; Wyss, 1981; Figure 3) and this projection
has weak bilateral component in the rat (10 % of ipsilateral; e.g., Goldowitz et al, 1975;
Steward and Scoville, 1976).  The granule cells of the dentate gyrus also receive inputs from
the contralateral (commissural) and ipsilateral (associational) hilar neurons.  The commissural
and associational (C/A) projections terminate in the inner one third of the molecular layer and
do not overlap with the entorhinal afferents in the outer 2/3 of the molecular layer (Gottlieb
and Cowan, 1973; Deller et al., 1995).  This layer, the inner one third,  also receives a
relatively dense input from the supramammillary nucleus of the hypothalamus (Wyss et al.,
1979).  Another source of extrinsic innervation to the dentate gyrus originates in the septum
and the nucleus of diagonal band of Broca.  These areas send axons (containing acetylcholine
or GABA as neurotransmitter) to the DG with relatively dense terminals in the outer two
thirds of the molecular layer and the hilus, with less dense terminals in the areas just above
and below the granule cell layer (Kohler et al., 1984; Freund and Antal, 1988; Dutar et al.,
1995).  Except for a small crossed projection, the septal projection is primarily ipsilateral
(Segal and Landis, 1974; Peterson, 1989).  Other sources of innervation originate in brain
stem nuclei (the raphe nucleus and locus coeruleus) and (local) interneurons (Segal and
Landis, 1974; Azmitia and Segal, 1978). 
2.2.2. Hippocampus proper
The axons from the granule cells (the mossy fibers) leave the hilar region and synapse
on the proximal dendrites of the CA3 pyramidal cells, and this represents the second stage of
the trisynaptic loop.  It should be noted that the mossy fibers also terminate densely on the
mossy and basket cells of the hilus.   The basal dendrites of the CA3, CA2, and CA1
pyramidal cells ramify in  stratum oriens above the pyramidal cell layer, whereas the apical
dendrites are present below the pyramidal cell layer.  The area where the shafts of the apical
dendrites are located (with little branching) is called stratum radiatum, and the apical 
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Figure 3.
A, photomicrograph of a Nissl stained coronal section through the dorsal hippocampus, B, the
adjacent Timm’s stained section.  C, schematic drawing of the dorsal hippocampus indicating
the terminal fields of the lateral (LEC) and medial entorhinal cortex (MEC).  gcl-granule cell
layer, iml-inner molecular layer, mf-mossy fibers, mml-middle molecular layer, oml-outer
molecular layer, slm-stratum lacunosum moleculare.
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dendrites branch extensively in  stratum lacunosum-moleculare.   In CA3 there is an
additional layer called stratum lucidum located between the pyramidal cell layer and the
stratum radiatum, within which the mossy fibers course and terminate.  The axons of CA3
pyramidal cells project densely to CA1, as originally described by Schaffer (1892), but they
also give rise to relatively dense axonal arborizations within CA3.  The projection to CA1
represents the third stage of the trisynaptic loop. The CA3 projection to CA1 is bilateral and
mainly innervates stratum radiatum, and the basal dendrites in stratum oriens.  The ipsilateral
inputs are referred to as the Schaffer collaterals and the crossed input is referred to as the
commissural projection.  The main output from CA1 is to the subiculum, but some axons also
terminate in the entorhinal and prefrontal cortices (Amaral and Witter, 1989, Van Groen and
Wyss, 1990).  Local collaterals (and consequently the excitatory interactions among CA1
pyramidal cells) are extremely sparse (Lorente de No, 1934; Amaral and Witter, 1989; Van
Groen and Wyss, 1990; Amaral et al., 1991).  Many interneurons are present in CA3, CA2,
and CA1 (Freund and Buzsáki, 1996), and these have projections that, in general, are related
to the type of interneuron, e.g., basket cells primarily innervate the cell body layer.  Classes of
inhibitory cells exist in the CA fields that control the efficacy of different excitatory inputs,
since their dendrites are limited to one sublayer, e.g., either stratum oriens or stratum
lacunosum-moleculare, or with some interneurons, both.  
The major extrinsic inputs to hippocampus proper arise from the EC, the septum, the
nucleus of the diagonal band of Broca (NDBB), the nucleus reuniens and some brain stem
nuclei (Wyss et al., 1979).  The entorhinal input to the hippocampal formation is likely
glutamatergic (Nadler et al., 1976; White et al., 1977; Colbert and Levy, 1992).  In the rat,
stratum lacunosum-moleculare of CA1 receives input from an entorhinal projection
originating in the pyramidal cells of layer III (Steward and Scoville, 1976), whereas stratum
lacunosum-moleculare of CA3 is innervated by layer II stellate cells in the entorhinal cortex
(Steward and Scoville, 1976; Tamamaki and Nojyo, 1993).  Cholinergic and GABAergic
afferents emerging from the medial septum and the NDBB predominantly terminate in
stratum oriens and stratum radiatum of CA1 and CA3 (Kohler et al., 1984; Nyakas et al.,
1987; Freund and Antal, 1988).  However, the GABAergic axons predominantly innervate
interneurons in the hippocampus, thus disinhibiting the neurons.  CA1 receives a dense,
excitatory projection in stratum lacunosum-moleculare from the nucleus reuniens
(Wouterlood et al., 1990; Dolleman-van der Weel and Witter, 1996).  The hilus (below the
granule cell layer), and both CA1 and CA3 (stratum lacunosum-moleculare) receive a dense
serotonergic input from the dorsal and median raphe nuclei (Moore and Halaris, 1975).  A
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noradrenergic projection from the locus coeruleus densely innervates  the hilus and stratum
lucidum of CA3, where mossy fibers terminate, and less densely in stratum lacunosum-
moleculare of CA3 and CA1 (Jones and Moore, 1977).
The main extrinsic projections of CA1 are to the subiculum and EC, but other limbic
cortical areas, the lateral septum, the nucleus accumbens, and the olfactory bulb are also
among the targets of the CA1 subfield (Van Groen and Wyss, 1990).
2.2.3. Subiculum
The axons from the CA1 pyramidal cells synapse on the dendrites of the subicular
pyramidal cells, and this can be seen to represent the “fourth” stage of the trisynaptic loop. 
Unlike the pyramidal cells of CA3 and CA1, the pyramidal cells of the subiculum are not
arranged in one layer, they are more dispersed and show differences between the deeper and
more superficial neurons.  The apical dendrites of the pyramidal cells of the subiculum ramify
in the molecular layer.  The neurons of the deepest layer predominantly project to the anterior
nuclei of the thalamus, the more superficially located neurons project to the mammillary
bodies and the septum, nucleus accumbens and prefrontal cortex (O’Mara et al., 2001).  But a
substantial projection to the deeper layers of the caudal medial entorhinal cortex is also
present (Van Groen et al., 1987). 
2.3. Hippocampal sprouting following entorhinal cortex lesion 
The hippocampal formation has been shown to be a very suitable model system for the
study of neuronal plasticity following lesions, because of its relatively simple organization,
and its precise laminar pattern of terminal fields.  The well defined, and confined, areas of
axonal sprouting and synaptic remodeling make this cortical area a good model.  Further,
studies on lesions of the hippocampal formation have clinical relevance, for example, to
Alzheimer’s disease, epilepsy, and ischemic brain damage. 
During development, the central nervous system (CNS) is highly plastic, and is
characterized by massive circuitry rearrangement as neurons form appropriate connections
and survive, or make inappropriate connections and are eliminated (Oppenheim, 1991;
McConnel, 1995).  For many years, neuroscientists believed that neurogenesis - the
generation of new neurons - was restricted to early brain development.  New findings have
challenged this view and currently many neuroscientists believe that the capacity for circuitry
rearrangement is maintained throughout life.  The ability to reorganize synaptic connections
in the adult brain is most readily observed in response to CNS injury.
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The physiological ability to reorganize synaptic connections is retained by the adult
brain even under pathological conditions (Lynch and Cotman, 1975; Cotman and Nadler,
1978; Cotman et al., 1981).  After CNS trauma, surviving neurons form new synapses that
replace those lost by the lesion.  This reactive synaptogenesis was initially described by Liu
and Chambers (1958) in the spinal cord and by Raisman (1969) in the brain.  Since then,
lesion-induced forms of neuronal plasticity have been demonstrated in numerous species and
brain regions ( Goodman et al., 1973; Steward and Messenheimer, 1978; Flohr and Precht,
1981).  Together, these studies have increased the hope that mechanisms may exist which 
lead to a functional recovery of the brain following trauma, and, possibly, an amelioration of
functional deficits in the course of neurodegenerative disease (Moore and Zigmond, 1994).
One of the most studied systems in brain plasticity following injury has been the
regrowth of entorhinal axons in to the dentate gyrus of the rat following unilateral entorhinal
cortex lesions (reviewed by e.g., Steward, 1989; Deller and Frotscher, 1997; Cotman, 1998). 
This pathway is also of particular interest because of its critical role in higher cognitive
functions such as learning and memory, and because of its vulnerability to degeneration in
AD as well as during the course of aging (e.g., Hyman et al., 1990).  In this model, unilateral
ablation of the entorhinal cortex results in nearly complete denervation of the outer 2/3 of the
molecular layer of the dentate gyrus, and it is followed by sprouting and reinnervation of the
molecular layer by undamaged fibers in the denervated area.  Following unilateral ablation of
the entorhinal cortex, the outer two-thirds of the ipsilateral dentate gyrus molecular layer
loses 80-90% of its input, while no denervation occurs in the inner one-third of the molecular
layer that contains the associational and commissural axons that are not lesioned.  The early,
“degeneration” phase is characterized by degenerating axons and terminals in the molecular
layer of the dentate gyrus, that are removed rapidly by microglia and astrocytes ( McWilliams
and Lynch; 1979; Jensen et al., 1994).  In the rat, the degeneration is relatively rapid, and
complete, between 4 and 9 days postlesion, but signs of degeneration are present one month
after the lesion, and even 240 days after the lesion degenerating terminals can be found
(Matthews et al., 1976a).  Degenerating terminals are being removed from the first day after
the lesion by activated microglia (Gall et al., 1979); microglia has been shown to become
activated within 24 h postlesion and it is maximally activated by 3 days postlesion (Jensen et
al., 1994).  A similar time course for the microglial reactivity in the dentate gyrus following
entorhinal cortex lesions has been demonstrated in the mouse (Kadish et al., 1999). 
Astrocytes react slightly more slowly to the denervation, the first signs of activated astrocytes
are found two days postlesion, with the period of maximal activation around 6-7 days
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postlesion (Jensen et al., 1994).  The later, “regeneration” phase (which, in the rat, starts
approximately one week after the lesion) is characterized by reinnervation of the denervated
zone, i.e., the sprouting of new axons and axon collaterals, and the formation of new
terminals and synapses in the denervated part of the molecular layer of the dentate gyrus
(Matthews et al., 1976b; Steward and Vinsant, 1983).  Approximately 60-80% of the synapses
lost after denervation in the outer two-thirds of the molecular layer are subsequently replaced
by the new formation of synapses from remaining fibers in the denervated and adjacent areas
(Cotman and Berchtold, 1998).  In the rat, axons which sprout into the denervated zone arise
from three major surviving afferent fiber systems which normally project to the dentate gyrus:
projections from the contralateral entorhinal cortex, and the more sparse cholinergic (and
possibly the GABAergic) projections from the septum and NDBB, and the commissural-
associational pathway of the hilar neurons of the DG.  In addition to the compensatory
sprouting which occurs in denervated regions, study of the unilateral ECL model in the rat has
revealed that there is also a rearrangement of neural circuitry in nondenervated areas of the
CNS, i.e., in areas which are not primarily associated with the lesion (Hoff et al., 1981). 
Following EC lesions, they observed rearrangements in the inner molecular layer of the
dentate gyrus, a region which does not receive input from the EC.   Despite the absence of
degenerating synaptic terminals in the inner molecular layer following ECL, there is a
significant decline in synaptic density in this region and a subsequent recovery of synaptic
density to control levels over a long period of time (Hoff et al., 1981).
It has been proposed to differentiate between “axonal regeneration” and “regenerative
sprouting” as two distinct axonal responses to axotomy (Moore and Zigmond, 1994; Steward,
1994). “Axonal regeneration” implies the successful and specific reconnection of an
axotomized neuron with its target structure, while “regenerative sprouting” describes the
response of the proximal axon stump to regenerate, leading to multiple local axon collaterals
without the restoration of normal connectivity.  Axonal regeneration and regenerative
sprouting are processes that occur at the proximal stump of an injured axon.  In contrast,
sprouting, terminal proliferation and reactive synaptogenesis occur in the area deafferented by
the lesion and involve surviving fibres in or near the denervated zone.  These processes lead
to the reinnervation of the denervated target cells and to a restoration of the number of
synapses.  Based on electron microscopic observations, the formation of new synapses has
been termed “reactive synaptogenesis” (Raisman, 1969; Matthews et al., 1976a,b; Lee et al.,
1977; Cotman and Nadler, 1978; Steward and Vinsant, 1983).
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2.4. Species comparison
Most of our knowledge of the organization and connections of the hippocampal
formation has been derived from studies in the rat, as a cursory glance at the literature will
show.  Generally it has been assumed that the pattern of connections of the hippocampus
exhibited in the rat is indicative of that in most mammals.  However, careful studies on the
intrinsic and commissural connections have shown that relatively large species differences are
present, even in this “old, archicortical” part of the brain, Van Groen and Wyss (1988).  The
internal organization of the hippocampal fields, such as the hilar region has also been shown
to be quite different between species (Van Groen and Wyss, 1988).  Similarly the physiology
and organization of the limbic system are dissimilar in different species (Lopes da Silva et al.,
1990).  Whereas the main transmitters in the limbic system are similar, i.e., glutamate and
GABA, many of the neuropeptides and calcium-binding proteins show quite clear species
differences (e.g., Lopes da Silva et al., 1990).  Furthermore, it should be noted that clear
differences in learning and memory have been demonstrated between different mouse strains
(e.g., Lipp et al., 1987).  Taken together, these data indicate that studies on different species
are a necessity before similarity in either the anatomy or physiology is assumed.  The
differences in pathology between Alzheimer’s disease mouse models and human AD patients
are another example.
2.5. Alzheimer’s disease
 Alzheimer’s disease (AD) is the most common form of senile dementia.  It is
characterized by a progressive cognitive impairment and a brain specific neuropathology such
as the abundant occurrence of amyloid $ (A$) plaques, neurofibrillary tangles, and neuronal
and synaptic loss (Selkoe, 1991).  In AD some brain areas, primarily temporal cortex and
hippocampus, exhibit substantial loss of nerve terminals (and proteins associated with
synapses), and it has been suggested that this decrease may be the primary pathological
change or may accompany neuronal loss, neurofibrillary tangle formation, and/or neuritic
plaque formation (DeKosky and Scheff, 1990; Masliah et al., 1989; 1991).  The pattern of
pathological changes in the temporal cortex in AD is relatively consistent between
individuals, with, in general, the first neurofibrillary changes affecting primarily layers II and
IV of EC and the CA1/subicular fields (Braak and Braak, 1985; Hyman et al., 1988; 1990). 
Furthermore, neuritic plaques are commonly found in the perforant pathway terminal zone in
the outer two thirds of the dentate molecular layer in AD patients (Gibson, 1983; Hyman et
al., 1988).  Amyloid deposits in these regions are an invariant pathological feature of AD and
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result from the aggregation of a 39 to 42 amino acid long protein known as amyloid $ protein
(Selkoe, 1996). 
Whilst many investigators believe that increased A$ levels and A$ plaque formation
are critical to the pathogenesis, others argue that A$ and plaque formation are an
epiphenomenon (e.g., Neve and Robakis, 1998; Joseph et al., 2001).
 Autosomal dominant early onset AD is caused by mutations of the amyloid precursor
protein (app) gene and the presenilin1 (ps1) and presenilin2 (ps2) genes.  Each of these affect
APP metabolism and, therefore, A$ protein production (e.g., Price and Sisodia, 1998).  APP
is processed by three secretases, "-, $-, and (-secretase; the action of "-secretase leads to the
production of "-APPs, and when followed by (-secretase lead to the production of the P3
fragment.  $-secretase activity produces $-APPs, however, when this is followed by the (-
secretase, A$ is produced (Esler and Wolfe, 2001).  PS1 has been shown to be either the (-
secretase itself, or to be part of the enzyme complex.  The aberrant metabolism of APP may
be causally related to the development of dementia by leading to the formation of neuritic
plaques, and loss of synapses and neurotransmitters in the medial temporal lobe memory areas
and cortical associational regions (Braak and Braak, 1990; Price and Sisodia, 1998). 
Abnormal APP function has been suggested to lead to neurodegeneration in AD by: 1) direct
toxicity of elevated levels of aggregated A$ (Selkoe, 1993), 2) disruption of synaptic function
(Masliah, 1995), 3) deficient neuroprotective activity against excitotoxicity (Mattson et al.,
1993a,b; Mucke et al., 1995), and/or any combination of above mentioned.  The direct toxic
role of the fibrillar A$ protein alone in vivo is controversial.  Mutations in the ps1 gene have
been shown to alter APP processing, resulting in an increase of the more amyloidogenic A$1-
42 vs A$1-40 (e.g., Borchelt et al., 1996),  the 42-amino acid peptide form of A$, which is the
major component of the amyloid plaques that are present in the brains of AD patients (Storey
and Cappai, 1999).  PS1 not only plays a role in APP processing, but it has also been shown
to be involved in cortical development, i.e., PS1 has been shown to play a major role in the
Notch signalling pathway (e.g. Haass, 1997; Saftig et al., 1999; Zhang et al., 2000).  Other
recent studies have shown that PS1 could play a more direct role in brain plasticity, e.g., mice
expressing a human ps1 gene containing an AD mutation display increased hippocampal
long-term potentiation compared to mice expressing the normal gene (Pigino et al., 2001). 
Transfected neuroblastoma cells expressing ps1 mutations demonstrate impaired neurite
outgrowth compared to non-transfected cells (Dowjat et al., 1999).  In contrast, a recent study
has demonstrated that ps1 mutations deregulate neurite growth, i.e., in differentiated neurons
a ps1 mutation promotes a marked increase in total neurite length (Pigino et al., 2001). 
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Further, increases in neuronal plasticity appear to contribute importantly to the development
of the pathological hallmarks of AD (i.e., to the development of plaques and tangles
[Mesulam, 1999]).
2.6. Estrogen
Studies, performed in animals, suggests that estrogen is a trophic hormone in the brain
not only at the time of fetal development, but it exerts its neurotrophic effects in the adult as
well, i.e., the adult brain remains highly plastic and hormone-modulated (e.g., Beyer, 1999). 
For instance, Toran-Alerand et al. (1976; 1984) demonstrated that estrogen elicits selective
enhancement of neurite growth and differentiation (both axons and dendrites), using cultured
slices of the developing rodent brain.  This growth-promoting property of estrogen has been
confirmed subsequently in steroid target regions of the adult brain (Gould et al., 1990;
Woolley et al., 1990; Woolley and McEwen, 1992).  Trophic effects have been reported in
regions of the brain that express estrogen receptor mRNA, protein, and binding as well as
regions that appear to be receptor poor. 
Shughrue et al. (1997) has shown the distribution of the " and $ isoforms of estrogen
receptor mRNA in the adult rat brain, and he has demonstrated that there are significant
differences between the distributions of the two isoforms, with the " isofrom predominantly
present in brain areas that are related to sexual functioning.  The colocalization of estrogen
receptors, neurotrophins, and their cognate receptors as shown by Gibbs et al., (1994)
suggests potential interactions between estrogen and neurotrophins.  Several studies suggest
that estradiol may show growth promoting effects by influencing the expression of the
neurotrophins, nerve growth factor (NGF), brain derived neurotrophic factor (BDNF),
neurotrophin 3 (NT3) and neurotrophin 4/5 (NT4/5).  In addition, estradiol may influence
their receptors and the pan-neurotrophin receptor, p75NTR.  During development estradiol
receptor mRNA colocalizes with NGF, BDNF and NT3 in subsets of cells in the cortex and
hippocampus (Miranda et al., 1993b).
Previous studies have shown that estradiol induces structural and functional changes
in the excitatory input to hippocampal CA1 pyramidal cells of the adult female rat.  Removal
of endogenous estrogen by ovariectomy decreases the density of dendritic spines on the apical
dendritic tree of CA1 neurons (Gould et al., 1990; Woolley and McEwen, 1993; McEwen et
al., 1999).  Treatment with estradiol can either prevent (Gould et al., 1990) or reverse
(Woolley and McEwen, 1993) the ovariectomy-induced decrease in spine density.  Estrogen
rapidly potentiates CA1 pyramidal cells’ response to excitatory input evoked either by
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synaptic stimulation (Wong and Moss, 1992; Foy et al., 1999) or by glutamate receptor
agonists (Gu and Moss, 1996).  Treatment with estradiol in vivo increases synaptic
excitability of CA1 neurons with a delayed time course that parallels the changes in dendritic
spine/synapse density.  Estrogen has been shown to regulate neuronal function through at
least two distinct mechanisms with different time courses.  
The rapid effects of estrogen occur too quickly to involve genomic action of classical
estrogen receptors, but delayed effects that could involve genomic mechanisms have been
shown.  Estradiol may exert trophic and protective effects by acting via genomic mechanisms
on a variety of genes including the neurotrophins and their receptors, cell death proteins and
structural proteins that control maintenance of synapses and neurite outgrowth.   Estradiol
may further exert tropic and protective effects by influencing the expression of genes that
code for survival factors in the brain.  Pike (1999) found that in hippocampal cells, estrogen
increased Bcl-xL in a paradigm of amyloid toxicity.  Bcl-2 and Bcl-xL can act upstream in
cellular signalling to prevent the pro-apoptotic actions of bax, inhibit free radical production
and may regulate calcium sequestration.  The induction of this family of genes may have
multiple downstream effects, which together suppress apoptosis and favour cell survival
(MacManus and Linnik, 1997). 
There is accumulating evidence that estrogen exerts effects by novel mechanisms that
are different from those involving transactivation, nuclear receptor dimerization and binding
to consensus estrogen response elements.  Multiple different second messenger pathways,
including cAMP ( Zhou et al., 1996; Murphy and Segal, 1997) or MAP kinases (Watters et
al., 1997) may be involved.  Some of these novel mechanisms of estrogen action may require
cross-talk with the estradiol receptors.  Other trophic and protective effects of estrogen occur
in the absence of any known intracellular estrogen receptor (Green et al., 1998) and are
detectable within minutes.  This strongly suggests that estrogens may act either on a
membrane receptor or may act by influencing membrane receptors that are linked to ion
channels (Gu and Moss, 1996; Moss et al., 1997). 
Several lines of evidence suggest that a mechanism involving an estrogen-signalling
pathway may contribute to a lowered risk for AD.  It is recognized that there is a gender
difference in the prevalence of AD in women which cannot be solely accounted for by
longevity.  After menopause, a declining estrogenic stimulus, either from dramatically
reduced levels of circulating estrogen (or from aromatizable androgen levels), both of ovarian
origin in the female, might make estrogen target neurons in the brain more susceptible to age-
or disease-related processes such as AD.  It has been reported that the risk of developing AD
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and cognitive decline is lower in women with a history of hormone replacement therapy
(HRT) use during the postmenopausal period (Paganini-Hill and Henderson, 1994; Tang et
al., 1996).  Furthermore, women with AD exibit beneficial responses to cholinesterase
inhibitor medications only if they are also receiving estrogen replacement therapy (Schneider
et al., 1996).  However, recently, it has been reported that short term estrogen therapy does
not improve cognitive symptoms after AD is established (Henderson et al., 2000), but a
neuroprotective role of estrogen or benefits of long term administration of estrogen remain
possibilities that are supported by epidemiological studies.  Several mechanisms may
contribute to the relation of estrogen state to AD.  Estrogen has been shown to act as a
neuroprotectant and neurotrophic agent, it can also enhance s-APP secretion and it can
prevent A$1-42 aggregation in vitro.  Steroid hormones such as 17$-estradiol are signal
transduction compounds which can regulate APP metabolism in vitro (Jaffe et al., 1994;
Chang et al., 1997; Xu et al., 1998). From a therapeutic standpoint the modulation of APP
metabolism via signal transduction pharmacology might be beneficial in individuals with, or
at risk for, AD (Gandy et al., 1994) and 17$-estradiol via its possible ability to elevate protein
kinase C activity could be identified as a potential modulator of A$ metabolism.  Estrogen
can exert antioxidant effects (Behl et al., 1997), and modulate expression of a number of
growth-related proteins, including apolipoprotein-E, GAP-43, neurotrophic factors and
neurotrophic factor receptors (Gibbs et al., 1994; McMillan et al., 1996; Singer et al., 1996;
Gibbs, 1998). 
Finally, estradiol may exert protective effects by acting on second messenger
pathways such as the nitric oxide pathway.  Pelligrino et al. (1996) have reported that
estradiol appears to enhance neuronal NOS expression and activity, which leads to an
improved vasodilation capacity.  Further, estrogen may also regulate glial reactivity to
disturbances in the milieu, thereby constituting another potential mechanism of estrogen
mediated neuroprotection in AD (Blurton-Jones and Tuszynski, 2001). Therefore, these
trophic and protective actions of estrogen may provide insight into clinical observations of
improved cognitive function and decreased neurodegeneration in hormone-replaced women. 
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3. AIMS OF THE STUDY
The present study was designed to characterize the projections from the entorhinal
cortex to the hippocampal formation in mice, to describe the differences in hippocampal
sprouting following entorhinal cortex ablation between mice and rats, and to evaluate the
effects of (AD-related) mutations and hormones on lesion-induced synaptic plasticity in the
hippocampus of mice.
 The specific aims were:
1)  to study in detail the connections between the entorhinal cortex and the
hippocampal formation in mice by using anterograde and retrograde tracing
methods, and to describe both the origin and the laminar distribution of the
projections from the entorhinal cortex to the hippocampal formation in the
mouse, and compare these findings to the rat data. (I, II)
2) to describe the similarities and differences between mice and rats in lesion-induced
sprouting in the hippocampus. (IV)
3) to examine the effects of the presence of the mutated human presenilin 1 (ps1) gene
on lesion-induced sprouting in the hippocampus of the mouse. (III)
4) to evaluate the effects of estrogen depletion and supplementation on axonal
sprouting in the mouse hippocampus. (V)
34
4. MATERIALS AND METHODS
4.1. Animals (I-V)
Male, adult C57BL/6J mice (n=69) were used in publication I and II, in publication II
also 70 adult male rats (Sprague Dawley; Charles River, Wilmington, MA) were used.  In
publication III, transgenic mice ( n=41, C57xCBA) overexpressing wild type or mutated
(M146L mutation) human ps1 were used, these lines of animals were generated as described
previously (Leutner et al., 2000).  F2 animals of these lines were shipped to Kuopio three
months before the experiments.  The transgene expression is under the control of the human
HMG-CR-Promotor that represents a housekeeping-type promotor which showed a strong
and ubiquitous expression pattern with high expression in neurons (Czech et al., 1997). 
Adult, female mice (n=15, C57BL/6J strain; National Laboratory Animal Center, Kuopio)
and adult female rats (n=15, Wistar; National Laboratory Animal Center, Kuopio) were used
in publication IV.  For publication V 45 female C57BL/6J mice (National Laboratory Animal
Center, Kuopio) were used.
Prior to surgery all animals were housed 2 to 3 per cage, at constant humidity (60 ±
5%), temperature (22 ± 1o C) and light cycle (06:00-18:00).  Following surgery all animals
(including sham controls) were housed individually.  All procedures were approved by the
Animal Use and Care Committee of the University of Kuopio, the State Provincial Office of
Eastern Finland, and followed the guidelines of the European Communities Council Directive
of 24 November 1986 (86/609/EEC).
4.2. Anterograde tract-tracing with BDA (I, II)
 Mice were anaesthetized with a mixture of a sodium pentobarbital and a chloral
hydrate solution (50/50;i.p.; 36 mg/kg); the head was shaved and placed in a stereotaxic frame
such that the skull was horizontal.  A small hole was drilled in the skull at the appropriate
coordinates.  Glass micropipettes (10-20 :m tip) filled with a 10% solution of biotinylated
dextran amine (BDA; Molecular Probes, 10,000 MW, Eugene (OR)) in phosphate buffer (pH
7.4) were lowered into the entorhinal cortex, and a positive pulsed DC current was applied for
15-20 min to the solution. Coordinates for the injection site were adapted from the atlas of
Franklin and Paxinos (1997).  Seven to fourteen days later, the mice were reanesthetized,
perfused, and the brain was removed from the skull.
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4.3. Retrograde tracing with fluorescent dyes (I, II)
For confirmatory, retrograde transport experiments, a small (10-30 nl) amount of a
fluorescent dye (fast blue [FB], 4% in DH2O, Illing, Germany; or fluorogold [FG], 4% in
dH2O, Fluorochrome, Inc. Englewood, CO) was injected by pressure into the hippocampus in
the animals.  In a small number of animals two retrograde tracers were injected at different
positions on the septotemporal axis of the hippocampus so as to be able to estimate the degree
of overlap between different populations of entorhinal cortex neurons projecting to the
hippocampus.  Similarly, in a few animals the two retrograde tracers were injected into one
side of the hippocampus each, to be able to estimate the degree of overlap between ipsi- and
contralateral projecting entorhinal neurons.  After a 7-10 day survival period mice were
reanesthetized, perfused, and brain was removed from the skull.
 
4.4. Histological methods (I-V)
All mice were deeply anaesthetized with a mixture of a sodium pentobarbital and a
chloral hydrate solution (50/50;i.p.; 50 mg/kg), and transcardially perfused with 50 ml of
buffered saline, followed by 100 ml of a 4% buffered (pH 7.4) paraformaldehyde solution to
which picric acid (0.5%) was added.  The brains were removed from the skull and stored in
the fixative for 4 hours, thereafter they were transferred to a 30% sucrose solution.  Rats were
deeply anaesthetized with sodium pentobarbital (80 mg/kg) and transcardially perfused with
100 ml of buffered saline, followed by 200 ml of a 4 % buffered (pH 7.4) paraformaldehyde
solution to which 0.5 % picric acid was added.  The brains were removed from the skull and
stored in the fixative for 4 hours, thereafter they were transferred to a 30% sucrose solution.
The brains were sectioned in the coronal plane using freezing, sliding microtome (35:m
thick, one-in- six series).
We used a modification of the Timm’s sulphide silver method to illustrate the regional
architecture of the hippocampus and entorhinal cortex.  This method is based on the
precipitation of endogenous metals (e.g., zinc) with sulphide, and the visualization of these
metal sulphides with silver.  For Timm’s staining mice were anesthetized, and transcardially
perfused with 0.1 %  Na2S in 0.1 M phosphate buffer (pH 7.4) for two minutes, followed by
10 min with a 4 % paraformaldehyde solution, and continued with another 10 min of the Na2S
solution.  After perfusion the brain was removed from the skull, and following cryoprotection,
two series of 1 in 6 transverse sections were cut on a freezing microtome.  The sections were
collected in TBS and rinsed overnight prior to staining with the sulphide silver method
according to Danscher (1981).  In short, the sections were mounted on slides, and developed
36
with silver amplification (i.e., in the dark the sections were developed in a solution
containing: gum arabic, citrate buffer, hydroquinone, and silver lactate).  Following
development, the sections were rinsed, postfixed, and coverslipped. 
Detailed descriptions for immunohistochemical staining procedures are presented in
publications (I- V). The primary antibodies were monoclonal mouse anti-synaptophysin
(dilution 1:1000; Sigma) and mouse anti-GAP43 (1:1000; Sigma).  The monoclonal Anti-
Synaptophysin (mouse IgG1 isotype) is derived from the hybridoma produced by the fusion
of mouse myeloma cells and splenocytes from an immunized mouse. A synaptosome
preparation from rat retina was used as the immunogen.  The isotype is determined using
Sigma ImmunoTypeTM Kit (Sigma Stock No. ISO-1) and by a double diffusion immunoassay
using Mouse Monoclonal Antibody Isotyping Reagents (Sigma Stock No. ISO-2). 
Monoclonal Anti-Synaptophysin localizes the 38 kD band of synaptophysin in rat brain
extracts using an immunoblotting technique. The antibody reacts with human, guinea pig, and
pig synaptophysin.  The product localizes synaptophysin in neurons, neuromuscular junctions,
paraganglia cells, hypophysis, pancreatic islet cells and adrenal cells (Sudhof et al., 1986). 
Monoclonal Anti GAP-43 (mouse IgG2a isotype) is derived from the GAP-7B10 hybridoma
produced by the fusion of mouse myeloma cells and splenocytes from
BALB/c mice immunized with HPLC-purified GAP-43 from neonatal rat forebrain
membranes. The isotype is determined using the Sigma ImmunoType TM Kit (Sigma
Stock No. ISO-1) and by a double diffusion immunoassay using Mouse Monoclonal Antibody
Isotyping Reagents (Sigma Stock No. ISO-2).  Monoclonal Anti GAP-43 (Growth-Associated
Protein-43) recognizes an epitope present on both kinase C phosphorylated and
dephosphorylated forms of GAP-43.  The epitope detected by the antibody seems to be a
tertiary configuration, existing in all 3 isoforms of GAP-43 (Meiri et al., 1987).  The
biotinylated secondary antibodies were goat anti-mouse (1:400; Sigma) and goat anti-mouse
IgG* HRP (1:500; Pierce).  After primary and secondary antibody incubations, the sections
were reacted with ExtrAvidin (1:1000; part of the Mouse ExtrAvidin Peroxidase Staining Kit,
Sigma).  The immunoperoxidase reaction was developed in a Ni-enhanced DAB solution
(12.5 mg DAB in 25 ml 0.1 M phosphate buffer pH 7.4, 30 :l H2O2 (30%), with 1 ml of a
15% ammonium Ni-sulfate solution added).  The stained sections were mounted on
gelatinized slides, dried overnight and coverslipped.  Control sections in which the primary
antisera were omitted or in which normal serum was used revealed no detectable staining.  An
adjacent series of sections was stained with Nissl and one series of sections was
histochemically stained with acetylcholinesterase (AChE).
37
 
4.5. Entorhinal cortex lesions (III-V)
Mice were anaesthetized with a mixture of a sodium pentobarbital and a chloral
hydrate solution (50/50;i.p.; 36 mg/kg); the head was shaved and placed in a stereotaxic frame
such that the skull was horizontal.  The skull was surgically exposed and a hole was drilled at
the appropriate coordinates, and the needle (90 :m tip diameter) of a Hamilton 0.5 :l
microsyringe was stereotaxically lowered to the entorhinal cortex.  The coordinates for the
entorhinal cortex injection site were: A-4.3, L+4.1, and V-5.5 (Franklin and Paxinos, 1997). 
Two times 150 nl of ibotenic acid (10 mg/ml, Sigma) was injected, i.e., 2 injections (at V-5.5
and V-4.5, respectively) were made into the entorhinal cortex at a rate of 50 nl/min.  Adult
rats were anaesthetized with sodium pentobarbital (50 mg/kg); the head was shaved, and
placed in a stereotaxic frame such that the skull was horizontal (i.e., bregma and lambda were
at the same level).  The skull was surgically exposed and a hole was drilled at the appropriate
coordinates, and the needle (90 :m tip diameter) of a Hamilton 0.5 :l microsyringe was
stereotaxically lowered to the entorhinal cortex.  The coordinates for the two injection sites
were: A-6.0 , L+6.2 , and V-7.3; and  A-7.3 , L+5.0 , and V-7.8 (Paxinos and Watson, 1982).   
At each injection site,  400 nl ibotenic acid was injected into the entorhinal cortex at a rate of
50 nl/min.  
To assess the lesion size, the entorhinal cortex was digitized using a Nikon Coolpix
990 camera,  the images were converted to Grey Scale images with the Jasc Paint Shop Pro 7
program, the resulting pictures were analyzed using the ScionImage (NIH Image) program. 
The extent of the entorhinal cortex lesion was defined as the area that displayed a significant
loss of layer II and III neurons.  
4.6. Ovariectomy (V) 
For ovariectomy the mice were anaesthetized with a mixture of a sodium pentobarbital
and chloral hydrate solution (50/50; i.p., 36 mg/kg).  The animal was placed on its abdomen
and the skin on the back was shaved and sterilized.  A small, dorsal, midline incision was
made in the skin, approximately in the middle (antero-posterior) of the back, then a muscle
incision was made approximately halfway down the side of the body.  The ovaries were
visualized in the abdominal cavity and retracted from the body using a forceps (they were
removed by holding on to the periovarian fat).  The junction between the Fallopian tube and
the uterine horn was cut, the ovary removed and the uterine horn was replaced in the
abdominal cavity, and the wound was closed.  Following surgery (i.e., at the same day) a
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pellet containing 17 $ estradiol (Innovative Research of America, Sarasota, FL, USA) was
placed under the skin at the back of the neck.  These pellets release a steady flow of the
hormone for the duration of the experiment (i.e., 60 day release pellets).  The moderate (0.18
mg/p) dose pellets resulted in a moderate level of 75-100 pg/ml of estrogen in the blood, the
high (0.72 mg/p) dose pellets resulted in a high level of 300-400 pg/ml of estrogen in the
blood (Innovative Research of America, Sarasota, FL, USA).  To control for the efficacy of
the ovariectomy, and estrogen supplementation, following sacrifice the weight of the uterus
was measured.  
4.7. Measurements
The appropriate sections, and areas of the hippocampus were digitized using a Nikon
Coolpix 990 camera, and the images were converted to grey scale using the Paint Shop Pro 7
program.  The optical density in the appropriate bands of the molecular layer (outer or middle
molecular layer) of the ipsilateral (to the lesion) and contralateral dentate gyrus and in ipsi-
and contralateral CA1 (in the same sections) of the hippocampus were measured using the
ScionImage (NIH, NIMH, Bethesda, MD, USA) program.  These measurements were done on
the same section, or on the adjacent, simultaneously stained, section.  Density measurements
were performed by an investigator who was blind to the treatment of the animals.  For
analysis the optical density measurements were converted to relative densities, i.e., the
density of synaptophysin staining of the molecular layer of the contralateral dentate gyrus was
set as 100%.  Further, the width of the molecular layer (and inner molecular layer) of the
dentate gyrus and of stratum lacunosum-moleculare and stratum radiatum of CA1 was
measured.  All measurements were done in triplicate, i.e., measuring the same areas at three
different places in the dorsal hippocampus, but at the same lateromedial position in the
dentate gyrus and in CA1.  This was necessary since the width of these layers varies with the
lateromedial position of the measurement in the hippocampal formation.  Data were analyzed
by ANOVA (SPSS version 10.0), and post-hoc tests (Tukey and Scheffe) were carried out to
determine the source of a significant main effect(s) or interaction.
For the two dimensional reconstruction (I, II), three 1 in 6 series through the entire
extent of the hippocampus were digitized  using the Neurolucida program (MicroBrightField,
USA).  The outlines of the cortical hemisphere, the dentate gyrus, CA3 and CA1, and the
subiculum were plotted and the plots were aligned.  A two-dimensional unfolded map of the
dentate gyrus and hippocampus and entorhinal cortex was constructed following the
procedures of Swanson et al. (1978) and Dolorfo and Amaral (1998a).   The data were plotted
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on the two generic unfolded maps for al cases, since the variability between animals was
minimal (it should be noted that C57BL/6J mice are an inbred strain of mice, and are thus
geneticaly identical). 
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5.RESULTS
5.1. Organization of the projection from entorhinal cortex to the hippocampal formation
in the mouse (I)
The origin and the terminations of the projections from the entorhinal cortex to the
hippocampal formation of the mouse (C57BL/6J strain) have been studied using
anterogradely and retrogradely transported tracers.  The entorhinal cortex was principally
divided into two areas, i.e., the lateral entorhinal area (LEA) and the medial entorhinal area
(MEA).  LEA was the origin of the lateral perforant path that terminated in the outer one-third
of the molecular layer of the dentate gyrus, and MEA was the origin of the medial perforant
path that ended in the middle one-third of the molecular layer of the dentate gyrus.  This
projection was mostly to the ispsilateral dentate gyrus, only a few labeled axons and terminals
were found in the contralateral dentate gyrus.  The projection to the dentate gyrus originated
predominantly from neurons in layer II of the entorhinal cortex.  The entorhinal cortex also
projected to CA3 and CA1, and to subiculum, in both CA3 and CA1 the terminals were
present in stratum lacunosum-moleculare, whereas in the subiculum the terminals were in the
outer part of the molecular layer.  The projection from the entorhinal cortex to CA3, CA1, and
subiculum was bilateral, and it originated predominantly from neurons in layer III, but a small
number of neurons in the deeper layers of the entorhinal cortex contributed to this projection. 
The projection of entorhinal cortex to the hippocampus was topographically organized,
neurons in the lateral part of both LEA and MEA projected to the dorsal part (i.e., septal pole)
of the hippocampus, whereas the projection to the ventral (i.e., temporal pole) hippocampus
originated from neurons in medial parts of the entorhinal cortex. 
5.2. Differences in the organization of the projection from entorhinal cortex to the
hippocampal formation between the mouse and the rat (II)
Both differences and similarities exist among mammalian species in the projections
from entorhinal cortex to hippocampal formation.  We have analyzed these projections in
mice and compared them to the projections in rats; in general, the entorhinal cortex-to-
hippocampus projections are similar in mice compared to those in rats.  In the mouse, axons
from layer II neurons terminated in the outer and middle thirds of the molecular layer of the
dentate gyrus, and axons from layer III neurons terminated bilaterally in the stratum
lacunosum-moleculare of areas CA1 and CA3, and in the molecular layer of the subiculum. 
However, in contrast to rat, mouse entorhinal cortex neurons did not appreciably project to
41
the contralateral dentate gyrus.  Also there was smaller septotemporal extent of axonal fields
in the mouse.  Rats, compared to mice, showed a similar topographical organization of the
entorhinal-hippocampal projections, with neurons in the lateral part of both the lateral and
medial entorhinal cortex projecting to the dorsal part or septal pole of the hippocampus,
whereas the projection to the ventral hippocampus originated primarily from neurons in
medial parts of the entorhinal cortex. 
5.3. Differences in lesion-induced hippocampal plasticity between mice and rats (IV)
5.3.1. Sprouting in the mouse
In the EC-lesioned mice a large, significant (ipsilateral compared to contralateral;
p<0.001) increase in synaptophysin staining density was present in the outer part of the
molecular layer of the dentate gyrus four weeks following the lesion.  It should be noted that
the axons of the EC also terminate in stratum lacunosum-moleculare of CA1, however no
change in synaptophysin staining density was measurable in this layer in the mouse, and no
change in staining density was present in any other area of the hippocampus.  Our data also
showed that the mouse did not display any significant shrinkage in the width of the molecular
layer of the dentate gyrus following partial ECL, neither did the outer molecular layer show a
change in width in a mouse, and none of the mice showed a change in the width of stratum
radiatum and stratum lacunosum-moleculare of ipsi- or contralateral CA1.  The change in
density of staining for synaptophysin was also reflected in material stained for AChE.  The
change in AChE staining density was, however, not as consistent as the increase in
synaptophysin staining.
5.3.2. Sprouting in the rat
Similarly, in the rats that received unilateral ECL a significant (ipsilateral compared to
contralateral; p<0.001) increase in synaptophysin staining density was present in the outer
molecular layer of the dentate gyrus.  However, the rats also demonstrated a significant
(p<0.005) increase in the staining density of stratum lacunosum-moleculare of CA1.  In
contrast to mouse, the rat did show a significant decrease (77% of the contralateral size;
p<0.001) in the size of the molecular layer of the dentate gyrus.  The outer molecular layer
(where the lesioned lateral EC axons terminate) actually shrunk to 52% of the contralateral
size (p<0.001), the middle molecular layer of the dentate gyrus also decreased in width. 
Further, the rat showed a small, but significant (approximately 10%; p<0.05), decrease in the
size of stratum lacunosum-moleculare.  None of the rats showed a change in the width of the
inner molecular layer of the dentate gyrus after partial ECL.
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In both species the lesions of the lateral EC lead to changes that were limited to the
lateral perforant path terminal field in the dentate gyrus, and these density changes were
confined to the septal, dorsal part of the hippocampus.  However, in the rat the staining
density for synaptophysin in the lateral perforant path terminal field in stratum lacunosum-
moleculare of CA1 in the dorsal part of hippocampus was also upregulated, in contrast to the
mouse where this upregulation in CA1 was not present.  No significant changes were present
in other, more ventrally located parts of the dentate gyrus or CA1 (areas that are not
denervated by the lesion), either in the mouse or the rat. 
 
5.4. Effects of the presence of the mutated human presenilin 1 gene (M146L; hps1*) on
lesion-induced sprouting in the hippocampus of the mouse (III) 
In the normal mPS1 mice (the negative litter mates of the human PS1* expressing
animals), four weeks following the entorhinal cortex lesions, there was no change in the
density of staining for synaptophysin in the molecular layer of the dentate gyrus ipsilateral to
the lesion. In hPS1* mice a large, significant increase in synaptophysin staining density (i.e.,
a sprouting response) was present, and in the hPS1 mice the response was similar in size. 
Both groups of mice demonstrated a significant increase (F(2,18) = 9.79; p < 0.001) in the
density of synaptophysin staining compared to the normal, mPS1 mice.  It should be noted
that the axons of the entorhinal cortex also terminated in stratum lacunosum-moleculare of
CA1, however no change in synaptophysin staining density was measurable in this layer.  
The change in density of staining for synaptophysin was also reflected in the material
stained for AChE, this material also showed an increase in the staining intensity.  The change
in AChE staining was, however, not as consistent as the increase in synaptophysin staining. 
Some animals showed a significant change in synaptophysin but not in AChE staining. 
Further, it should be noted that none of the animals showed an increase in AChE without an
accompanying change in synaptophysin. 
5.5. Effects of estrogen on axonal sprouting in the mouse hippocampal formation (V)
The data demonstrate that in control mice, four weeks following the lateral entorhinal
area lesions there was a significant increase (from 100 % to 119.5 ± 4.4 %) in the density of
staining for synaptophysin (i.e., sprouting) in the outer one-third of the dentate gyrus
molecular layer ipsilateral to the lesion.  Both the mouse groups that received ES displayed a
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similar sprouting response following the entorhinal cortex lesion (M-ES from 100%  to 121.3
± 3.8 %, and H-ES from 100%  to 126.0 ± 3.8 %, respectively).  However, in mice that were
ovariectomized and did not receive estrogen supplementation (i.e., the OE group) the
sprouting response was substantially reduced (i.e., no change,  100 % and 100.1 ± 0.5 %,
compared to all other groups, F(3,30) = 6,75; p < 0.001).
Measurements of the synaptophysin staining density demonstrated that the change was
confined to the ipsilateral dentate gyrus.  No measurable changes in staining were present in
ipsilateral CA1 (where the entorhinal axons also terminate) or in contralateral CA1, or in any
other areas of the ipsi- or contralateral hippocampus. 
 Further, it should be noted that the change in staining density for synaptophysin was
also reflected in material stained for AChE, i.e., this material also showed an increase in
staining density.  In control mice after EC lesion there was an increase (from 100% to 126.7 ±
5.9 %; p< 0.05) in the density of staining for AChE in the outer one-third of the dentate gyrus
molecular layer ipsilateral to the lesion.  The two mouse groups that received ES displayed a
similar sprouting response following the EC lesion (M-ES from 100% to 127.9 ± 8.5 %
[p<0.05] and H-ES from 100% to 118.8 ± 6.4% [p<0.05], respectively). However, in mice
that were ovariectomized and did not receive ES, the sprouting response was substantially
reduced (100% and 100.1 ± 1.2 %).  Nevertheless, these changes in density were not
significantly different between the groups (F(3,26) = 2,81; p <0.06), since each group had a few
animals where AChE staining was either not changed, or changed very little.  Again, no
visible changes in density of AChE staining were present in any other area of the ipsi- or
contralateral hippocampus.
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6. DISCUSSION
6.1. Methodological aspects
6.1.1. Comments on the nomenclature of the mouse entorhinal cortex and hippocampal
formation
These studies employ the mapping of Van Groen (2001) of the mouse entorhinal
cortex.  The entorhinal cortex (EC) is subdivided into two main parts, i.e., the “classical”
lateral entorhinal area (LEA) and the “classical” medial entorhinal area (MEA).  LEA is
further subdivided into three fields: dorsolateral entorhinal field (DLE), dorsal intermediate
entorhinal field (DIE) and ventral intermediate entorhinal field (VIE), and MEA is subdivided
into two fields: caudal entorhinal field (CE) and medial entorhinal field (ME; Van Groen,
2001).  
The hippocampal formation has been classified according to Ramón y Cajal (1893)
and Slomianka and Geneser (1991a,b, 1993).  In the present studies the division of the
hippocampal formation into a septal (i.e., dorsal) and a temporal (i.e., ventral) pole according
to Blackstad (1956) is used.  
We have employed a modified Timm’s stain as a histochemical marker of the afferent
systems of the dentate gyrus, three bands of staining can clearly be distinguished in the
molecular layer of the dentate gyrus in Timm’s stained material (Geneser et al., 1993; Figure
3).  It should be noted that in the molecular layer of the dentate gyrus of the mouse, the two
bands of the lateral and medial perforant path are wider than the inner band of labeling (which
only occupies approximately 17 % of the total of stratum moleculare; West and Andersen,
1980).  The inner band of the molecular layer primarily contains the terminals of the
associational and commissural axons of the hilar neurons.  However, for ease of reading we
have employed the terms outer and middle one third of the molecular layer in our descriptions
of the terminal fields of the lateral and medial entorhinal cortex, respectively.   Further, the
width of stratum lacunosum-moleculare in CA1 is comparatively larger in the C57BL/6J
mouse than it is in the rat (West, 1990).
6.1.2. Immunohistochemical controls
The specificity of the antibodies used in the present series of the studies were
previously described (Meiri et al., 1986; Sudhof et al., 1987; Calhoun et al., 1996).  
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6.1.3. Synaptophysin immunoreactivity as a tool to study reactive synaptogenesis in the
mouse hippocampal formation
Sprouting, a form of neuronal plasticity, can be identified by staining for GAP-43 or 
synaptophysin - a 38kDa calcium-binding glycoprotein (Südhof, 1987) -  found in the
membranes of presynaptic vesicles.  GAP-43 (growth-associated protein-43; another protein
that is present in the presynaptic terminal) has been used as a marker for sprouting (e.g.,
Namgung and Routtenberg, 2000), but our results indicate that there are no differences in the
upregulation of these two proteins (i.e., an increase in the staining density in the lesioned
dentate gyrus molecular layer) following entorhinal cortex lesions.  However, staining for
GAP-43 is less reliable than staining for synaptophysin in the mouse (McNamara et al.,
1996).  Taken together with the fact that most other research in sprouting in the mouse has
used synaptophysin as a marker of sprouting (e.g., Calhoun et al., 1996), we have used only
synaptophysin immunocytochemical staining as an indicator of changes in synaptic density in
the rest of the experiments.  It has been shown that during development the expression of
synaptophysin increases parallel with the formation of synapses, and synaptophysin
immunoreactivity matches completely with the distribution of synaptic profiles.  Although
this technique does not allow for any differentiation between synapse type or neurotransmitter
identity, it enables an estimate of presynaptic terminal density over a wide area of the
neuropil (Masliah et al., 1990; Eastwood and Harrison, 1995).  This method has been
extensively used to demonstrate synaptic loss (characteristic of e.g., Alzheimer’s disease;
Terry et al., 1991) and synaptic loss following experimentally induced lesions such as
perforant path transection and entorhinal cortex ablations (Masliah et al., 1991; Kirkby and
Higgins, 1998).
6.1.4. Use of transgenic animals
Despite intensive efforts, a fully authentic transgenic mouse model of AD has not yet
been created.  Nevertheless, overexpression of mutant proteins or single AD-associated
molecule in various transgenic mouse lines has produced a variety of phenotypes that, as a
first approximation, are remarkably similar to the human AD condition, and these mouse
models are providing an assay system in which selected details of pathogenesis and
therapeutic intervention can be evaluated.  We have used several mouse models of AD to
study the effects of different mutations, i.e., transgenic mice overexpressing wild type (wt) or
mutated (M146L mutation) human ps1 that were generated as previously described (Czech et
al., 1998).  The presence of the transgene (wt or mutated transgene) was monitored by
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polymerase chain reaction (PCR) using oligomers for the human ps1 gene.  Following the
shipping of the animals to Kuopio, they have been kept in Kuopio. 
6.2. Interpretation of results 
6.2.1. Organization of the projection from entorhinal cortex to the hippocampal  formation
in the mouse
The perforant path is generally subdivided in a lateral and a medial component, arising
in the lateral (LEA) and medial (MEA) entorhinal cortex, respectively (e.g., Hjorth-Simonsen,
1972).   These two perforant paths show different staining densities in Timm’s stained brain
sections, with the lateral perforant path staining more densely than the medial perforant path
(e.g., Haug, 1974; West and Andersen, 1980; Fredens, 1981; Figure 3).  Further, it has been
demonstrated that there are other physiological and histochemical differences in the lateral
and medial perforant path (e.g., Witter et al., 1989a).  It should be noted that the cat and
rhesus monkey display a clear laminar division in medial and lateral perforant path endings in
the dentate gyrus, whereas the macaque monkey does not show this division (e.g., Van
Hoesen and Pandya, 1975; Witter et al., 1989b; Witter and Amaral, 1991).  Similar to most
other species, the mouse shows a division in lateral and medial perforant path endings in the
dentate gyrus, demonstrated both by the Timm’s stained material and in our anterograde
tracing studies (Stanfield et al., 1979).  It should be noted that in the mouse the entorhinal
cortex terminals occupy a larger part of the molecular layer of the dentate gyrus than in the rat
(West and Anderson, 1980), but there are also differences in the size of the area occupied by
the perforant path endings between different mouse strains ( Stanfield and Cowan, 1979;
Fredens, 1981; unpublished observations).  
Comparable to all other species, in the mouse the projection from the entorhinal cortex
to the dentate gyrus originates exclusively in layer II neurons.  A large number of studies in
many species have demonstrated that predominantly neurons residing in layer II of the
entorhinal cortex project to the dentate gyrus.  In the rat, the layer II cells of the EC have been
shown to project to the dentate gyrus (e.g., Segal and Landis, 1974; Steward and Scoville,
1976; Ruth et al., 1982; 1988, Tamamaki and Nojyo, 1993; Deller, 1998; Dolorfo and
Amaral, 1998b), and a distinct projection to the contralateral dentate gyrus is present. 
Further, comparable to findings in the rat by Deller (1998) and Deller et al. (1996) we noticed
a small projection from the entorhinal cortex that terminates outside the “normal” perforant
path area (i.e., outside of the outer two-thirds of the molecular layer of the dentate gyrus). 
These EC terminals are present near (above and below) and within the granule cell layer. 
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Comparable to most other species, in the mouse the projection from the entorhinal
cortex to CA3 and CA1 terminates in stratum lacunosum-moleculare (Stanfield et al., 1979). 
In CA1 the axons from LEA terminate near the subiculum (i.e., in CA1c), whereas the MEA
terminals are found near CA3, i.e., in CA1a and in CA1b.  In the rat the terminals from the
entorhinal cortex in CA3 and CA1 are present in stratum lacunosum-moleculare.  In the
mouse and the rat these projections are similarly radially organized (Steward, 1976; Wyss,
1981; Witter et al., 1989a).   In the mouse the projection from the entorhinal cortex to CA3
and CA1 originates predominantly from neurons in layer III, however a small number of
neurons in the deeper layers of the entorhinal cortex contributes to this projection.  In contrast
to the rat, in the mouse the layer II neurons of the entorhinal cortex do not seem to project to
CA3.  
In the mouse, the projection from the entorhinal cortex to the subiculum originates
predominantly from neurons in layer III, however a small number of neurons in the deeper
layers of the entorhinal cortex contributes to this projection.  In the rat the innervation of the
subiculum similarly derives from neurons in layer III of both LEA and MEA, but
predominantly from lateral parts of these areas (Witter et al., 1989a).  
The rat, the rabbit, and the cat show a distinct projection from the entorhinal cortex to
the contralateral dentate gyrus, which is, however, limited to the septal part of the dentate
gyrus (Goldowitz et al., 1975; Hjorth-Simonsen and Zimmer, 1975; Steward and Scoville,
1976; Wyss, 1981; Witter and Groenewegen, 1984), in contrast, in the mouse the projection
to the contralateral dentate gyrus is extremely modest and limited to the septal tip of the
dentate gyrus only.
In the rat the EC-DG organization has been studied most extensively (Hjorth-
Simonsen, 1972; Steward, 1976; Wyss, 1981; Ruth et al., 1982, 1988; Pohle and Ott, 1984;
Dolorfo and Amaral, 1988; Amaral and Witter, 1989).  Together, these studies have
demonstrated that the EC-DG projection in the rat is topographically organized such that,
lateral parts of the entorhinal cortex principally terminate in the septal part of the dentate
gyrus, whereas medial parts of the entorhinal cortex primarily terminate in the temporal part
of the dentate gyrus.   The mouse demonstrates a similar organization, i.e., lateral EC-to-
septal DG and medial EC-to-temporal DG, of this projection.  However, it should be noted
that these lateral and medial zones in the entorhinal cortex cut across the cytoarchitectonically
defined borders of LEA and MEA.  This arrangement of the medial and lateral zones in the
entorhinal cortex that project, respectively, to temporal and septal parts of the hippocampus is
similar to what has previously been described in the rat by Dolorfo and Amaral (1988) and cat
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by Witter and Groenewegen (1984).
Several studies have indicated that functional differences exist between dorsal and
ventral parts of the hippocampus in the rat, these are related to differences in inputs between
medial and lateral areas of the entorhinal cortex  (e.g., Witter et al., 1989a; Moser and Moser,
1998).  Lateral parts of entorhinal cortex predominantly receives inputs from cortical
multimodal sensory areas, whereas medial parts of the entorhinal cortex receive inputs that
are more related to visceral information.  The existence of a relatively similar topographical
organization of the projection from the entorhinal cortex to the hippocampal formation in the
mouse (compared to the rat) suggests that a similar functional difference likely exists in the
mouse.  
6.2.2. Differences in the organization of the projection from entorhinal cortex to the
hippocampal formation between the mouse and the rat
 Most of the differences between mice and rats in the projection from the entorhinal
cortex to the hippocampus were outlined above (6.2.1),  In short, in the rat the projection from
the entorhinal cortex to the contralateral dentate gyrus is primarily confined to the septal part
of the dentate gyrus, this contralateral projection is practically nonexistent in mice.  However,
mice, similar to rats and cats, have a relatively large projection from the entorhinal cortex to
contralateral CA3, CA1 and subiculum.
In rats, the layer II cells of the EC have been shown to project to the dentate gyrus,
similarly, in mice the projection from the entorhinal cortex to the dentate gyrus originates
predominantly from layer II neurons, and only a very small number of neurons in deeper
layers of the entorhinal cortex contribute to this projection.
Comparable to most other species, in mice, the projection from the entorhinal cortex
to CA1 and to the subiculum originates predominantly from neurons in layer III, however a
very small number of neurons in the deeper layers of the entorhinal cortex also contributes to
this projection.  In the mouse, CA3 is predominantly innervated by the neurons from layer III
of the entorhinal cortex, in contrast, in rats the projection from the entorhinal cortex to CA3
originates predominantly from layer II neurons.
The projection of the entorhinal cortex to the hippocampal formation is organized
topographically.  Injections into the lateral part of LEA label axons and terminals in the
dorsal, septal third of the hippocampal formation.  In contrast, an injection into the more
medial part of LEA gives rise to labeled axons and terminals in the intermediate
(septotemporal axis) part of the hippocampal formation, and injections into the medial part of
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LEA label terminal fields in the ventral, temporal part of the hippocampal formation.   Thus,
injections that are situated increasingly more medial in LEA give rise to terminal fields in the
hippocampal formation that are located more and more ventrally (temporal).  A similar
organization of the hippocampal terminal fields is found following MEA injections.  In
summary, neurons that are in the lateral part of the entorhinal cortex (from both medial and
lateral entorhinal areas) project to the dorsal third (or septal pole) of the hippocampal
formation, whereas the projection to the ventral third of the hippocampal formation originates
from neurons that are located in medial parts of the entorhinal cortex.  Similar to the mouse,
the rat EC-DG projection is topographically organized such that lateral parts of the entorhinal
cortex terminate in the septal part of the dentate gyrus, whereas medial parts of the entorhinal
cortex predominantly terminate in the temporal part of the dentate gyrus.  
Our data demonstrate that in comparison to rats, the mouse, in general, has a similar
organization of the EC to hippocampal formation projection.  The primary species difference
is the lack of an appreciable contralateral projection from EC to DG in the mouse.  However,
mice have a more extensive projection to the contralateral entorhinal cortex, thus
communication with the other hemisphere takes place at a different level of information
processing.  Further, the mouse EC to DG projections have a smaller septotemporal extent
than in the rat, indicating stronger functional differences between dorsal and ventral
hippocampus in the mouse.  This reiterates the need to carefully characterize the connections
in a species/strain prior to comparative studies within that species/strain.  
6.2.3. Differences in lesion-induced hippocampal plasticity between mice and rats
 This study demonstrates that the process of neuronal reorganization in adult female
mice (C57BL/6J) is very similar to that shown by adult female rats (Wistar).  However, the
process of neuronal regeneration shows differences in the response to denervation.  
 The staining pattern for synaptophysin in the dentate gyrus molecular layer shows
some differences between the sham (i.e., normal) mice and rats.  In our material, the inner
one-third of the molecular layer of the dentate gyrus is stained more densely in the mouse
than in the rat (e.g., Cabalka, 1992; White et al., 2001), however, others have shown a
staining pattern for synaptophysin in the molecular layer of the dentate gyrus of the rat that is
more similar to our mouse pattern (e.g., Masliah et al., 1991).  Some of these variations in the
staining pattern for synaptophysin in the mouse are probably attributable to the use of
different primary and secondary antibodies (unpublished observations, Masliah et al., 1991;
Cabalka, 1992).  The use of different rat and mouse strains probably further contributes to the
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observed differences (unpublished observations).  However, we have analyzed the data such
(we compared the non-lesioned side with the lesioned side) that differences in staining
density, that are a relatively common problem in immunohistochemical techniques, and that
are present in our material between batches stained at different times, are circumvented (e.g.,
Calhoun, 1996). 
The results show that there are no differences between rats and mice in the
upregulation of the presynaptically expressed protein synaptophysin (Südhof, 1987) in the
dentate gyrus molecular layer following entorhinal cortex lesions.  Both species display an
increased staining density, which suggests sprouting and/or an increased number of
presynaptic elements four weeks following unilateral entorhinal cortex lesions.  These
experiments also demonstrate a clear relation between the position of the lesion in the
entorhinal cortex and the band of increased staining in the molecular layer of the dentate
gyrus.  The lesions of the lateral part of the lateral entorhinal cortex (that we use in this study)
result in changes in staining density only in the lateral perforant path terminal field in the
dorsal, septal hippocampus (Wyss, 1981; Dolorfo and Amaral, 1998; Van Groen et al., 2001). 
It should be noted that in the mouse there are no significant changes in the density of
synaptophysin staining in other parts of the lateral entorhinal cortex terminal field in the
hippocampus (i.e., in areas CA3 and CA1).  In contrast, the rat does show an increased
density of staining for synaptophysin in stratum lacunosum-moleculare, but this layer is more
densely innervated by the lateral entorhinal cortex in the rat than in the mouse (Wyss, 1981;
Van Groen et al., 2001). 
It can be argued that due to shrinkage of the molecular layer of the dentate gyrus there
is an increase in the density of staining for synaptophysin (e.g., Wagner et al., 1983). 
However, in contrast to earlier studies in the rat (e.g., Van Groen et al., 2001) the molecular
layer of the dentate gyrus of the mouse does not show shrinkage following unilateral
entorhinal cortex lesions.  It should be noted that Stone et al. (1998) actually have
demonstrated an increase in the size of the outer molecular layer of the dentate gyrus of the
ovariectomized female mouse with estrogen replacement therapy, two weeks following
perforant path transection.  In contrast, our data from the rat agree with earlier findings in the
rat demonstrating shrinkage of the molecular layer of the dentate gyrus following entorhinal
cortex lesions (Steward, 1991).  Similar to our data, Steward and Vinsant (1983) have shown
a decrease in the size of the molecular layer to about 75 % of the contralateral molecular layer
at 12 days post-lesion.  Further, this decrease in width has been shown by Diekmann et al.
(1996) to be accompanied by significant shortening in the size of the dendritic tree of the
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dentate granule cells, measurable even 60 and 270 days following entorhinal cortex lesions. 
They demonstrated that the denervated dendrites do not reach the hippocampal fissure any
more, but terminate in the middle molecular layer of the dentate gyrus.  In the mouse the
shortening of the apical dendrites of the granule cells of the dentate gyrus does not seem to
occur (unpublished observations).  It should be noted that our measurements of the width of
the molecular layer (and outer molecular layer) of the dentate gyrus correspond to earlier
published data (Steward and Vinsant, 1983; Steward, 1991; Deller and Frotscher, 1997; Stone
et al., 1998). 
The analysis of the sprouting in the denervated zone of the dentate gyrus following
entorhinal cortex lesions is, however, not only related to sprouting of surviving entorhinal
cortex neurons.  In the rat several fiber systems have been shown to participate in the
reinnervation of the dentate granule cell dendrites following entorhinal cortex lesions.  In the
rat, the normally sparse, crossed entorhinal-dentate pathway proliferates within the
denervated zone (e.g., Steward et al., 1974; Steward and Vinsant, 1983).  However, since the
mouse does not have an appreciable contralateral projection from the entorhinal cortex to the
hippocampus (Van Groen et al., 2002), the sprouting in the mouse most likely derives from
the axons of the non-lesioned neurons of the ipsilateral entorhinal cortex (Steward and
Vinsant, 1978).  Further, in the rat it has been demonstrated that following entorhinal cortex
lesions there is an upregulation in the density of the cholinergic fiber system innervating the
dentate gyrus molecular layer (Lynch et al., 1972; Nadler et al., 1977; Forster et al., 1997),
the alterations in the AChE staining density that we have seen in this study are probably
related to changes in this fiber system (Slomianka and Geneser, 1993).  Thus, the possibility
of concomitant sprouting of cholinergic septal axons can therefore not be excluded, since an
increase in staining density in AChE in the molecular layer of the dentate gyrus is present in
our AChE stained material, similar to the descriptions in the rat.  It should be noted that the
synaptophysin staining does not allow to distinguish between types of presynaptic terminals
(Calhoun et al., 1996).   In the rat it has also been shown that there is an expansion of the
terminal field of the commissural/association system into the zone formerly occupied by the
entorhinal axons and terminals following complete entorhinal cortex lesions in young animals
(Lynch et al., 1976; Staübli et al., 1984).  We have not been able to replicate this finding, we
do not see any significant increase in the width of the commissural/associational system of the
dentate gyrus (the inner part of the molecular layer).  Thus, this increase in the size of the
associational system does not seem to happen following partial entorhinal cortex lesions in
either the adult, female mouse or rat.  However, it should be noted that a recent study using
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apoE transgenic mice has demonstrated an increase in the size of the inner molecular layer
following an unilateral entorhinal cortex lesion with ibotenic acid (White et al., 2001).  
Together, the data from these experiments suggest that a real change in the number of
presynaptic terminals (i.e., the density of innervation) in the molecular layer of the dentate
gyrus is present in the mice following entorhinal cortex lesions, whereas in our data from the
rat this is less clear (see above; Steward, 1991; Kelly and Steward, 1998).  However, many
electron microscopic studies in the rat have demonstrated that regeneration is present in the
molecular layer of the dentate gyrus following entorhinal cortex lesions (e.g., Matthews et al.,
1976b; Steward and Vinsant, 1983).  Taken together, this suggests that the rat and the mouse
show a similar reinnervation of the dentate gyrus molecular layer following lesions of its
main input, the entorhinal cortex, but the response to denervation is different between these
two species.  In the rat the denervated molecular layer shrinks in size (and the dendritic tree
shrinks), whereas this does not occur in the mouse. 
6.2.4. Effects of the presence of the mutated human presenilin 1 gene (M146L; hps1*) on
lesion-induced sprouting in the hippocampus of the mouse
Recent studies have shown that PS1 could play a role in brain plasticity (Selkoe,
2000).  Mice expressing a human ps1 gene containing an AD mutation display increased
hippocampal long-term potentiation compared to mice expressing the normal gene (Parent et
al., 1999).  It has been shown that PS1 is induced in surviving neurons in the hippocampus
following transient ischemia (Tanimukai et al., 1998), suggesting that PS1 expression might
be related to protection or recovery of damaged neurons in vivo.  Further, recently it has been
demonstrated that in the rat following entorhinal cortex lesions there is an upregulation in
both APP and PS1 mRNAs in the hippocampus (Ramirez et al., 2001).  In contrast to our
findings, it has been suggested that Alzheimer’s disease linked ps1 mutations impair neurite
outgrowth in cell culture studies (Dowjat et al., 1999).  But, recently, another study
demonstrated that ps1 mutations deregulate neurite growth, such that in differentiated neurons
the ps1 mutation promotes a marked increase in total neurite length (Pigino et al., 2001). 
Similarly our data demonstrate that the presence of a familial Alzheimer’s disease mutation in
the ps1 gene increases the sprouting response following lesions in transgenic mice, but it
should be noted that the “normal” human  ps1 gene has the same effect.  The enhanced
sprouting can, therefore, be the result of the higher levels of PS1 protein present in these
animals (Czech et al., 1997), although most PS1 protein that is present in these animals is
human PS1 (Czech et al., 1997; Leutner et al., 2000).  In our mice the level of transgenic
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human PS1 slightly exceeds the level of endogenous murine PS1 that is present in normal
mice (Leutner et al., 2000), therefore the improved sprouting response could be caused by the
increased amount of PS1 protein.  However, high levels of the PS1 protein have been shown
to decrease plasticity in hippocampal neurons (Guo et al., 1999), making this explanation less
likely.  Further, the level of full-length PS1 is tightly regulated; PS1 is mostly present as the
cleaved C- and N-terminal fragments (Czech et al., 2000).  On the other hand, the enhanced
sprouting is most likely directly related to the functioning of PS1, and not to its effects on A$
processing since both the “normal” and the mutated human gene have a similar effect. 
However, an increased or decreased level of (or change in) APP processing with an effect on
sprouting cannot be completely ruled out ( Seabrook and Resahl, 1999; Czech et al., 2000). 
In a recent report (De Strooper et al., 1998) it was demonstrated that in transgenic mice that
lack the ps1 gene a decreased secretion of A$ is present in primary neurons cultured from
these mice, despite the normal level of the full length APP or the amyloidogenic COOH-
terminal fragment.  This argues for the notion that PS1 is an important factor for the
proteolytic processing of APP at the COOH-terminus of APP by (-secretase (De Strooper et
al., 1998).  A recent paper has confirmed these results by demonstrating that cells that have
both ps1 and ps2 knocked-out do not secrete any A$ (Zhang et al., 2000).  Moreover, very
recently it has been demonstrated that PS1 is either the gamma secretase itself and/or closely
associated with the gamma secretase complex (Esler et al., 2000; Herreman et al., 2000; Li et
al., 2000a,b).  Together, these data indicate that PS1 can directly influence plasticity (Mattson
and Guo, 1997; Parent et al., 1999) or can indirectly modulate plasticity through its actions on
APP processing (Czech et al., 2000) and thus change brain plasticity (Mattson, 1997; Selkoe,
2000).
These results demonstrate that the presence of either the normal human ps1 gene or
the mutated human ps1* gene in these transgenic mice, compared to the mouse ps1 gene,
enhances plasticity of the transgenic mouse brain following unilateral entorhinal cortex
lesions. 
6.2.5.  Effect of estrogen on axonal sprouting in the mouse hippocampal formation
These studies demonstrate that in mice, following ovariectomy, the axonal sprouting
response of the hippocampal formation to lesions of its main cortical input, the entorhinal
cortex, is substantially reduced.  Estrogen supplementation (ES), both at a moderate dose and
at a high dose, restores the sprouting response to the level of the non-ovariectomized, the
normal mouse.
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Following ovariectomy, with its concomitant reduction in estrogen levels, the uterine
weights of the mice are very much reduced, similar to findings in other studies (e.g., Ryan
and Schwartz, 1980; Stone et al., 1998).  In contrast, the uterine weights are increased
following ES compared to normal mice, as expected, since the moderate dose pellets of
estradiol (M-ES) result in blood levels of estrogen slightly above the normal, diestrous levels
of estrogen (i.e., 75 -100 pg/ml and 20 - 40 pg/ml, respectively; Bronson and Desjardins,
1974; Ryan and Schwartz, 1980).  Earlier studies have shown that there is a relation between
estrogen levels and uterine weight  (Bronson and Desjardins, 1974; Ryan and Schwartz, 1980;
Stone et al., 1998).  Similarly, following H-ES the uterine weights are significantly increased
compared to M-ES, since the implantation of the high dose pellets of estradiol results in blood
levels of estrogen somewhat above the normal, proestrous levels of estrogen (i.e., from
around 250 pg/ml to 300 - 400 pg/ml, respectively (Bronson and Desjardins, 1974; Ryan and
Schwartz, 1980).  We have not measured the blood levels of estrogen in our animals in this
study, since in a separate study we have measured these levels (Rissanen et al., 1999) and
they have been shown to be similar to the above levels.  Further, the amount of blood
necessary (approximately 0.25 ml) for measurement of the blood estrogen levels could have
interfered with the proper perfusion fixation of the animals which is essential for the semi-
quantitative immunohistochemistry.
Ovariectomy with the ensuing low estrogen levels can affect the size of the ibotenic
acid lesion, and thus the amount of the sprouting response.  However, no difference in the size
of the ibotenic acid lesion in the entorhinal cortex is present in the OE group compared to any
of the other groups. 
We have only measured changes in the synaptophysin (and AChE) staining density in
the dorsal, septal part of the hippocampus, since the axons arising from (the lesioned) lateral
parts of the entorhinal cortex predominantly terminate in this part of the hippocampus (Turner
et al., 1998; Van Groen et al., 2001).  Following the lateral entorhinal area lesions there is an
increase in the density of staining for synaptophysin in the outer one-third of the dentate
gyrus molecular layer ipsilateral to the lesion, however since shrinkage of this layer would
have affected the synaptophysin staining density measurements (e.g., Wagner et al., 1983), we
measured the width of the dentate gyrus molecular layer.  None of the groups of mice showed
any change in the width of the dentate gyrus molecular layer or in the width of stratum
lacunosum-moleculare+stratum radiatum of CA1.  In contrast, it should be noted that Stone et
al. (1998) showed an increase in the width of the outer molecular layer in estrogen-treated
wild-type mice following perforant path transection.
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Degenerating terminals are being removed from the first day of the lesion by activated
microglia (Gall et al., 1979), microglia becomes activated within 24 h postlesion and is
maximally activated by 3 days postlesion (Jensen et al., 1994).  It has been demonstrated that
microglia express estrogen receptors (Mor et al., 1999) and that estrogen has anti-
inflammatory effects on microglia (Mor et al., 1999; Bruce-Keller et al., 2000).  Thus the lack
of estrogen could have interfered with the functioning of microglial cells and therefore with
the clearance of debris, and this would have hindered regeneration.  However, in an earlier
study we have examined the activity of microglia and astrocytes, and there were no
differences between normal and OE animals two and four weeks after entorhinal cortex
lesions (Kadish et al., 2001).
The later, “regeneration” phase (which starts approximately one week after the lesion)
is characterized by reinnervation of the denervated zone, i.e., the sprouting of new axons and
the formation of new terminals and synapses in the molecular layer of the dentate gyrus
(Matthews et al., 1976b; Steward et al., 1990).  In our previous studies we have shown that
there are no differences in the upregulation of two presynaptically expressed proteins (i.e.,
GAP-43 and synaptophysin) following entorhinal cortex lesions, suggesting that there is an
apparent increase in the staining of presynaptic elements four weeks following ibotenic acid
lesions of the entorhinal cortex (Kadish et al., 2001).  Several electron microscopic studies in
the rat have demonstrated that regeneration of synapses is present in the molecular layer of
the dentate gyrus following entorhinal cortex lesions (e.g., Matthews et al., 1976b; Steward
and Vinsant, 1978).  Electrophysiological studies have indicated that the growth of new
synapses is accompanied by the re-establishment of the entorhinal evoked field potentials in
the dentate gyrus (West et al., 1975; Steward et al., 1983).  Further, Steward (1982) and
Ramirez (1997) have reviewed the functional significance of the entorhinal cortex lesion-
induced plasticity in the hippocampus, they have demonstrated that the time-course of the
ingrowth of entorhinal cortex axons corresponds with the improvement in behavior and
electrophysiological properties.    
Several fiber systems have been shown to participate in the reinnervation of the
dentate granule cells following entorhinal cortex lesions in rats.  Thus, the analysis of the
effects of entorhinal cortex lesions on sprouting in the denervated zone of the dentate gyrus is
complex since several fiber systems could sprout into the denervated part of the molecular
layer of the dentate gyrus.  In the mouse the crossed entorhinal-hippocampal pathway is
practically non-existent (Van Groen et al., 2001), and therefore not likely to contribute
significantly to the sprouting response.  Further, Lynch et al., (1972) and Zimmer (1973) have
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shown in young rats that there is an expansion of the terminal field of the
commissural/association system into the zone formerly occupied by the entorhinal axons and
terminals following complete entorhinal cortex lesions.  West (1984) and Deller and Frotscher
(1997) have demonstrated a similar expansion of the commissural fiber system following
entorhinal cortex lesions in the adult rat.  However, no change in the size of the layer
occupied by this system is present in our animals.  In contrast, White et al. (2001) have shown
an expansion of the inner molecular layer in human apoE transgenic mice.  Likely these
differences are (partly) caused by the partial entorhinal cortex lesions (with degeneration of
the lateral perforant path only) in this study compared to complete entorhinal cortex lesions in
the other studies.
It has been demonstrated that the AChE containing septohippocampal pathway
proliferates within the denervated zone (e.g., Lynch et al., 1972; Nadler et al., 1977a,b). 
Nonetheless, no change in choline acetyltransferase (ChAT) staining is present following the
entorhinal cortex lesions in the mouse (Kadish et al., 1999).  Likewise, the change in density
of staining for AChE is not related to an actual increase in axon number (Calhoun and
Mouton, 2001; preliminary studies).  High power analysis of the zone of upregulated AChE
staining shows a higher density of staining per axon, and clumps of AChE associated with
axons, together this indicates a higher expression of AChE per axon.  Besides, it should be
noted that not all entorhinal cortex lesions result in significant changes in AChE staining,
whereas all lesions result in significant changes in synaptophysin staining.  Further,
Henderson et al. (1998) have demonstrated in the rat an apparent increase in the density of
ChAT containing terminals following unilateral entorhinal cortex lesion.  However, they
concluded that this apparent increase in staining density could entirely be accounted for by
the tissue shrinkage.  In contrast, it should be noted that Nyakas et al. (1988) demonstrated an
increased innervation from the septum to the hippocampus following unilateral entorhinal
cortex lesions in the rat.  Together, this may indicate that possibly some of the non-
cholinergic (i.e., GABAergic) septal axons possibly sprout following entorhinal cortex
lesions.  But it should be noted that these axons mainly terminate on interneurons and are
relatively sparse.  
Ovariectomy per se also influences the cholinergic system, Luine (1985) has shown a
significant decrease in ChAT staining in the hippocampus two weeks following ovariectomy
in the mouse, but Gibbs et al. (1994) have demonstrated that four weeks following an
ovariectomy the ChAT levels in the hippocampus have returned back to normal.  Therefore
we assume that the ovariectomy did not negatively affect our measurements of the changes in
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ChAT staining density (Kadish et al., 1999).  We do, however, show a significant increase in
the density of staining for AChE following the entorhinal cortex lesion in the mouse,
indicating that this enzyme is upregulated in the hippocampus.  This would also concur with
the suggestion that AChE has a function in regulating plasticity as such (Small, 1989). 
 The sprouting response in the dentate gyrus following entorhinal cortex lesions is
dramatically reduced in ovariectomized animals, suggesting that a lack of estrogen leads to a
reduction in plasticity.  This hypothesis is corroborated by the results of the ES mouse groups,
since the estrogen supplementation in the ovariectomized mice enhanced the regeneration
response of the brain to lesions to a level similar to that of normal, non-ovariectomized mice.  
Many studies have suggested that estradiol is a trophic hormone in the brain during
fetal development (e.g., Beyer, 1999).  In recent studies it has been demonstrated that the
adult brain remains highly plastic and hormone-regulated (e.g., Garcia-Segura et al., 1994;
Desmond and Levy, 1997), and estradiol influences this plasticity by acting as an important
trophic and protective factor throughout the life span, even in the human brain (Garcia-
Estrada et al., 1993; Garcia-Segura et al., 1994; McEwen and Alves, 1999).  Estradiol’s
neurotrophic effects are many: induction of neurite outgrowth, dendritic spines and
synaptogenesis, influence on long term potentiation and excitability, and enhancement of
gene expression (e.g., Garcia -Segura et al. 1994; Desmond and Levy, 1997; McEwen and
Alves, 1999).  Our findings that estradiol maintains the plasticity of neurons suggests that
neurons may experience resistance to injury and/or facilitated regeneration from injury.  It has
been shown that sex differences are present in the reaction of the rat brain to injury (Milner
and Loy, 1980; Morse et al., 1986), and that estrogen supplementation modulates axonal
sprouting and/or the regeneration of lesioned neuronal processes (Morse et al., 1992).
Estradiol may exert its trophic and protective effects by acting via classic genomic
mechanisms (i.e., through the estrogen receptor) on a variety of genes including the
neurotrophins and their receptors, cell death proteins and/or structural proteins that allow
maintenance of synapses and neurite outgrowth (e.g., McEwen and Alves, 1999).  There are
two known estrogen receptors, ER-" and ER-$, and the colocalization of estrogen receptors,
neurotrophins, and their cognate receptors suggests potential  interactions between estrogen
and neurotrophins (e.g., Gibbs et al., 1994).  Further, estradiol may exert direct protective
effects by modifying blood flow (Mendelsohn, 2000).  These effects are both short-term, i.e.,
direct modulation of vascular smooth muscle cell relaxation, and long-term, i.e., through
estrogen receptor-mediated changes in gene and protein expression (Mendelsohn, 2000). 
Another pathway through which estrogen could exert its effects is by means of the non-
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genomic membrane receptors and their signaling pathways (such as cAMP and IP3 [Beyer,
1999; McEwen and Alves, 1999]).
In summary, our data demonstrate that low levels of estrogen lead to a reduction in the
sprouting response in the dentate gyrus following entorhinal cortex lesions, i.e., low estrogen
levels lead to a reduction in brain plasticity.  Numerous studies from humans and animal
models have suggested that estrogen may be beneficial in preserving cognitive function (e.g.,
Desmond and Levy, 1997; Henderson et al., 2000), further, in postmenopausal women
estrogen has been shown to help improve specific aspects of cognitive function (Fillit et al.,
1986; Brinton et al., 2000; Henderson et al., 2000).  The ability of gonadal steroids to
alleviate neurological symptoms has been addressed in human studies (Fillit et al., 1986). 
Further, recently it has been also reported that estradiol may be beneficial in
neurodegenerative diseases such as AD (Brinton et al., 2000; Henderson et al., 2000). 
Together, these data may provide a better comprehension of the clinical observations of
improved cognitive function and decreased neurodegeneration in women that receive
hormone replacement therapy.
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CONCLUSIONS
The goals of this thesis were to study and describe the projections from the entorhinal
cortex to the hippocampal formation in mice, and report the differences in these projections
between mice and rats.  Further, we report the differences in hippocampal sprouting following
entorhinal cortex ablation between mice and rats.  In addition, our aim was to evaluate the
effects of a ps1 mutation on lesion-induced synaptic plasticity in the hippocampus of mice
and to study the effects of different estrogen levels on this lesion-induced synaptic plasticity. 
From the results of these studies we can draw the following conclusions:
1)  the detailed study of the projections from the entorhinal cortex to the hippocampal 
 formation in mice demonstrated while in comparison to the primate, cat, and rat, the
mouse has, in general, a similar organization of the entorhinal cortex to hippocampal
formation projections, species differences are present in these connections.  The three
primary differences between mice and rats in the projections from the entorhinal
cortex to the hippocampal formation are: 1) the lack of an appreciable contralateral
projection from EC to DG, 2) layer III of the EC projecting to CA3 (in the rat it is
layer II), and 3) a more limited septotemporal extent of the labeling in the
hippocampus in the mouse compared to the rat.  This therefore reiterates the need to
carefully characterize (anatomically and physiologically) the connections in a species
prior to extrapolating from the results of studies in other (similar looking) species.
2) the description of the similarities and differences between mice and rats in lesion-induced
sprouting in the hippocampus. showed that differences between rats and mice exist in
the reaction of the hippocampus to deafferentation of its main input, the entorhinal
cortex.  The primary difference between rats and mice in the reaction of the
hippocampus to entorhinal cortex lesion is shrinkage of the denervated area in the rat,
but not in the mouse.  Further, in general, together these studies show, that, despite the
relatively common assumption, mice are not small rats.
3) the results from EC-lesion experiments in single transgenic mice demonstrate that the
presence of either the normal human ps1 gene or the mutated human ps1* gene in
these mice, compared to the mouse ps1 gene, enhances neuronal plasticity in the brain
following unilateral ECL.  Together, these data indicate that PS1 can directly
influence plasticity or indirectly modulate plasticity through its actions on APP
processing, and thus change the response of the brain to injury.
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4) Our studies on EC-lesions and the effects of ovariectomy, demonstrate that low levels of 
estrogen lead to a reduction in the sprouting response in the dentate gyrus following
entorhinal cortex lesions, i.e., low estrogen levels lead to a reduction in brain
plasticity.  These data may provide a better comprehension of the clinical observations
of improved cognitive function and decreased neurodegeneration in women that
receive hormone replacement therapy.
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